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In the recent years, infestation with salmon lice has become a major problem in salmonid farms, 
and has resulted in great economic losses and reduced welfare for farmed salmonids. To 
enhance the salmon lice combat, there has been an increased use of antiparasitic drugs in 
salmonid farms, raising concerns about the impact of these chemicals in the environment. In 
this study, an experiment with the non-target species pink shrimp (Pandalus montagui) was 
carried out to evaluate the effects of the antiparasitic drug teflubenzuron to crustacean living 
close to the farms. The pink shrimps (14.0±1.2 mm carapax length) were fed two times weekly 
for 46 days, with two doses of teflubenzuron. The two doses, termed low dose and high dose 
contained 0.1% and 1% of a normal fish therapy dose, respectively. At the end of the feeding 
experiment, surviving shrimps were examined for morphological changes, like speckled eyes 
and deformities, before tissue from the whole shrimp were analysed by LC-MS/MS to measure 
accumulated teflubenzuron in the shrimps.  Gene-expression analyses was performed to study 
the effect of teflubenzuron exposure at the transcriptional level, in addition to colorimetric 
analyses to monitor changes in protein carbonyl concentration and malondialdehyde levels, 
both indicating oxidative stress. 
Overall, the studies showed a high mortality rate (20%) among the shrimps exposed to high 
dose of teflubenzuron, whereas the small dose yield no mortality. Deformities like stiff and 
crocked legs were seen in both group receiving teflubenzuron. In the pharmacokinetic analyses, 
the mean concentration of teflubenzuron was significantly higher (10.5-fold) in the high dose 
group (70.39 ng/g w.w) compared to the low dose group (6.65 ng/g w.w). However, 
concentrations of teflubenzuron above LOQ (<0.2 ng/g w.w) were obtained in the control 
groups, suggesting that there might have been a contamination during the experiment. For this 
reason, extra shrimps from the same catch were added as an additional control to all sample 
analyses in this work, and all results are presented with initial controls and additional controls. 
The transcriptional data indicated that exposure of teflubenzuron at the studied concentrations 
could have a weak effect on antioxidative defence and detoxification mechanisms in shrimps. 
Moreover, correlation analyses suggested that teflubenzuron might have an impact on growth 
in shrimps. However, due to concentrations of teflubenzuron above LOQ in the controls, the 
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1.1 THE ATLANTIC SALMON INDUSTRY 
For centuries, seafood has been an important part of the Norwegian cuisine as well as an 
important commodity product. However, it was not until mid-19th century that fish farming was  
established as a commercial important sector, when the first hatcheries with eggs from 
salmonids were established in Norway (NLVF, 1981). In the beginning of the 20th century, 
farming of rainbow trout (Oncorhynchus mykiss) was organized, but the new commitment was 
less successful, and the interest for salmonid farming dropped. In the beginning of 1950, fish 
farming was re-established in Norway, with inspiration from the growing industry in Denmark. 
As there were some challenges posed by the cold climate in Norway, most of the full-year 
farming of fish in fresh water was limited to Hordaland and Rogaland (NLVF, 1981). The 
breakthrough of salmonid farming came in the beginning of 1970, as more effective methods 
like the use of floating pens were developed (Hovland et al., 2014; Steinset, 2017). 
Today, most of the salmonid farming is located along the coast from Rogaland to Finnmark 
(Svåsand et al., 2016) and for the last four decades, the salmon industry has been growing to 
become one of the largest industrial sectors in Norway. Worldwide, Norway is the leading 
exporter of Atlantic salmon (Salmo salar) and according to Statistic Norway (SSB), the total 
amount of traded salmon for 2015 was 1 303 346 ton, to a first-hand value of 44 439 million 
NOK. In the beginning of 2016, a five-kilo salmon had the same value as a barrel of oil (SSB, 
2016; Wig, 2016).  
However, infestation with salmon lice is a major challenge and causes severe problems for the 
aquaculture in Norway. Farmed fish are particularly vulnerable due to high density in the net 
pens, increased stress levels and at some areas, poor water quality (Langford et al., 2014). A 
positive correlation  between the amount of farmed fish and grade of  infecting lice at the same 
area is documented (Svåsand et al., 2016), and the annual economic loss is estimated to be 2.45 
NOK per kg salmon produced. This includes direct losses due to mortality and reduced growth, 
cost of treatment and extra manpower (Liu and Bjelland, 2014). The sea lice most frequently 
occurring in Norway is the salmon louse Lepeophteirus salmonis, and thus the background 
information given in this thesis, will concern this species. The salmon louse is a host specific 
ectoparasite, belonging to the order Decapoda. During its eight-stage lifecycle, the louse infects 
the fish and starts feeding of mucus, skin and blood. The eight stages can be divided into the 
platonic stages (nauplis 1&2), the infective stage (copepodit), the parasitic chalimus stage 
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(chalimus 1&2), the pre-adult stages (1&2) and an adult stage (Hamre et al., 2013).  During the 
first two stages, the lice feed on their stored nutrients, before they moult to the infective stage 
and search for a host.  At the chalimus stage the parasites are attached to the epidermis of the 
fish by a proteinous filament, before moulting to preadult stage (mobile stage) where they can 
move around and swim in the water column. The generation time for sea lice are depending on 
factors like salinity and temperature of the seawater. The newly hatched larvae develop poorly 
when salinity is below 25‰, and when salinity decreases to 15‰, the larvae do not survive 
(Marine-Institute, 2017). Increased water temperature results in faster production of adult lice, 
and greater chances of survival in the post-infection stage (Groner et al., 2016; Marine-Institute, 
2017). At 6°C, sea lice develops to mature lice within 8-9 weeks while at 12°C, sea lice can 
develop within 4 weeks (Marine-Institute, 2017). However, if the water temperature increases 
too much (30-34°C), the louse dies (Steinsvik, 2017).  
 
Salmon lice can cause wounds, reduced welfare and even death if the numbers are high enough. 
Mortality is often caused by secondary infections of pathogenic bacteria or virus, or by osmotic 
stress or anaemia (Devine et al., 2000). Smolt are more vulnerable than adult salmons when 
infected by sea lice, as the they are smaller in size and less tolerant to physiological changes 
(Liu and Bjelland, 2014).  
 
The Norwegian government has introduced legislation to enhance the salmon lice combat.  As 
the fish industry mainly uses open net pens (Steinset, 2017), salmon lice can easily move 
between farmed to wild fish, and negatively affects the wild salmonids. Infestation with sea lice 
in wild salmons has been related to intensive salmon production (Svåsand et al., 2016). The 
legislation require that farmers have to report to the Norwegian Food Safety Authority the total 
number of salmon lice per fish every 14th day if the temperature is below 4°C. When 
temperatures are at or above 4°C, the larvae develop faster and the farmers have to report every 
week. A mandatory treatment threshold has been set, and varies from seasoning and location of 
farm. Nord-Trøndelag and further south has a limit of 0.2 mature female lice per fish from 
Monday in week 16 to Sunday in week 23, whereas the threshold limit is 0.5 the rest of the 
year. In Nordland, Troms and Finnmark the limit is 0.2 mature female lice per fish from Monday 





1.2 TREATMENT AGAINST SALMON LICE 
There are several ways to threat salmonids infected by parasites. The most common are either 
by chemicals, mechanic removal or biological removal by using cleaner fish (lumpfish or 
wrasse) who feed on the attached lice. Cleaner fish is not considered by the Norwegian 
legislation as treatment, but as a method to keep the amount of lice under control (NFD, 2017). 
Mechanic removal involves all none-chemical methods like delousing laser, plankton shielding 
skirts (FHL, 2012; Aaen et al., 2015) or hot water (Steinsvik, 2017). Chemical treatment 
includes delousing in baths in an enclosed system and oral treatment with medicated feed. Use 
of chemotherapeutics has been a fast and effective treatment, however, problems with drug-
resistant parasites have led to an increased use of chemicals per kg the last years, and the use 
of drugs in combination have become more common (Table 1.2.1) (Svåsand et al., 2016). 
Changes in the legislation and lowered threshold for chemical treatment can also explain the 
increased sales. The numbers in Table 1.2.1, obtained from the Institute of Public Health (NIPH 
et al., 2017), shows the sale of antiparasitic agents used in treatment of salmon louse in selected 
years from 2006 to 2016. As can be seen, there have been an increased sale of antiparasitic 
agents per kg by 2015. In 2016, the sale of chemicals were reduced (a reduction of 
approximately 50% compared to 2015), most likely due to extended use of other methods, like 
mechanic removal, or the use of more potent chemicals (NIPH et al., 2017). Note that the 
numbers in Table 1.2.1 are given as kg active substance, and the doses given per m3 in bath 
treatment differs from 2 mg deltamethrin to approximately 2-3 g hydrogen peroxide. 
In contrast to other chemotherapeutics, the sale of the chemical teflubenzuron is still increasing.  
Teflubenzuron and diflubenzuron belongs to the benzoyl ureas, and were frequently used in the 
1990s and until 2001, before they were temporarily out of use from 2002 to 2008 due to 
environmental concerns and the effectiveness of other chemical treatments (Samuelsen et al., 
2014). However, the extended use of chemicals like the emametin benzoate and pyrethroids in 
the beginning of 2000, led to concerns about resistance in sea lice. In 2008 ineffective 
treatments with the pyrethroids and emamectin benzoate were reported, and the year after, there 
were also reports of failed treatments with azamethiphos (Aaen et al., 2015). As a result of this, 





Table 1.2.1: The sale of chemical against salmon lice. The numbers are given as active substance per kg of drugs 
(NIPH, 2017). b= bath treatment, d= in diet.  
 
1.3 TEFLUBENZURON 
Teflubenzuron [1-(3,5-dichloro-2,4-difluorophenyl)-3-(2,6-difluorbenzyol) urea]  can be 
distinguished from diflubenzuron by the additional halogenated functional group (Figure 1.3.1), 
and is considered more potent than diflubenzuron (Langford et al., 2011). Teflubenzuron is sold 
on the Norwegian marked as Ektoban vet® manufactured by Skretting. The drug is laced with 
fish oil to the surface of the feeding pellets, and given in doses of 10 mg per kilo fish for seven 
days (Felleskatalogen, 2016). The European Medicines Agency (EMA), formerly called The 
European Agency for the Evaluation of Medicinal products (EMEA) has performed a study 
with a single oral administrations of 10 mg teflubenzuron/kg salmon at different temperatures, 
indicating a low bioavailability and a temperature-dependent absorption.  
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In a single oral treatment of 10 mg 14C-teflubenzuron/kg  salmon at 10°C, the highest 
concentrations were found in the gall bladder, liver and kidney, and the chemical was 
distributed to muscle and skin with the highest concentration after 24 hours. In studies with 
repeated doses of 10 mg teflubenzuron/kg salmon, the highest concentration of teflubenzuron 
was detected in liver the first day. The major component detected for all tissue in both studies 
was unchanged teflubenzuron (EMEA, 1999), but five metabolites have been identified (SPC, 
2016). Moreover, studies of rats exposed to teflubenzuron, showed a rapid excretion of the drug 
and no signs of accumulation. The maximum residue limit (MRL) for teflubenzuron in 
salmonidae is set by EMEA to 500 µg/kg in muscle and skin in natural proposition (EMEA, 
1999).   
Salmon lice are affected by teflubenzuron when feeding on drug containing skin and blood, and 
the substance interrupts the synthesis of chitin [β-1, 4-N acetyl glucosamine linked polymer] in 
the exoskeleton of the louse (Felleskatalogen, 2016). Chitin occurs as an ordered, crystalline 
microfibril polymer and is an important part of the exoskeleton in crustacean, as it gives 
protection and stability. In many ways, chitin can be compared to collagen in vertebrates (Davis, 
2011). Inhibiting the synthesis of chitin before ecdysis (moulting), stops the organism from 
casting its exoskeleton (exuvium) and cause mortality for the louse. For this reason, 
teflubenzuron is only effective to lice that undergo moulting. A salmon louse moults several 
times during its generation time and the drug is most effective during the larvae stage where 
the moulting is most frequent. Adult lice do not undergo moulting and will be unaffected by the 
chemical (Langford et al., 2011).   
 
 
    
 
 





1.4 ENVIRONMENTAL CONCERNS 
While the pharmaceutical is almost non-toxic to other sea dwelling animals like fish, algae and 
shellfish, the benzoylurea pesticide can be highly toxic to animals depending on chitin. Given 
in diet, uneaten pellets (about 5-15%) represent a threat to benthic crustaceans like crabs, 
shrimps and lobster living close to the farming area.  Furthermore, pharmacokinetic studies 
show a bioavailability of approximately 10% in salmon, which means that approximately 90% 
of the drug is excreted in its active form in faeces (Olsvik et al., 2015). Due to low water 
solubility (0.0094 mg/L at 20 °C) and high lipophility (log Kow = 5.39) the majority of the active 
component is released bounded to particles in faeces and will degrade slowly in the sediment 
under and close to the farm (Samuelsen et al., 2015). It has been reported that teflubenzuron 
has an estimated half-life of 115 days in marine sediments, which indicates that the substance 
is present in the sediment for a long time after treatment (Langford et al., 2011). According to 
the summary of product characteristics (SPC), treatment with teflubenzuron should not be given 
at intervals less than 12 weeks, and used with caution from June to August when crustaceans 
go through moulting (SPC, 2016). However, there are few studies available on the 
ecotoxicological effects of teflubenzuron in marine crustaceans. Samuelsen et al. (2014) 
published a study on mortality and deformities in juvenile European lobster (Homarus 
gammarus) exposed to teflubenzuron, which showed that under controlled laboratory 
conditions, oral intake induced mortality and deformities in lobster during ecdysis (Samuelsen 
et al., 2014). There has also been a study on brown crabs (Cancer pagurus) and deep-water 
shrimps (Pandalus borealis) by Langford et al. (2014), were the authors caught crabs 100 m 
and 300 m from farming area, and deep-water shrimps 1-5 km away. The crabs contained up to 
538 ng/g teflubenzuron, whereas the shrimps only contained minor concentration (Langford et 
al., 2014). 
 
1.5 DETOXIFICATION KINETICS 
As most shrimps are omnivorous, teflubenzuron can be consumed when feeding on excess feed, 
faeces, plants or small animals close to the farm. There is little information available about the 
accumulation of teflubenzuron in shrimps. However, for chemicals in general, the 
hepatopancreas is the major organ for detoxification and elimination in shrimps. The 
hepatopancreas is surrounded by a thin membrane of connective tissue and is located in the 
cavity of the cephalothoracic. Five types of cell has been identified in the hepatopancreas, all 
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preforming individual task in the process of digestion, absorption and elimination of substances 
in shrimps (Sreeram and Menon, 2005). Elimination of some toxic substances have been 
suggested through faeces, gills or kidney in crustaceans (Ahearn et al., 2010), and there have 
been assumed that the enzymes of the cytochrome P450 and the glutathione-s-transferase (GST) 
family are important regulators of the detoxification processes for organic toxicants in shrimps 
(James and Boyle, 1998; Ren et al., 2014). As moulting in crustaceans has an impact on 
metabolism and other cell activity, stage of moulting can influence the toxicological effects of 
teflubenzuron (Faroongsarng et al., 2007).  
Toxicology experiments show mortality at seawater concentration of 5 µg/L diflubenzuron in 
crabs and pharmacological studies have shown structural deformities and an impact on 
reproduction and swimming behaviour due to exposure. The same studies also indicate that 
adult crustaceans were more tolerant than larval forms (Christiansen et al., 1978; Roth et al., 
1993). In studies of insects exposed to benzoylureas, the chemical have caused deformation and 
structural changes of  the peritrophic membrane (PM) surrounding the midgut epithelium, the 
epidermis and the tracheal system (Merzendorfer, 2013). The PM is found in a variety of 
invertebrate, including shrimps, and the membrane separates the ingested materials from the 
midgut epithelium (Martin et al., 2006). The influence on numerous tissues and cells indicates 
that the antiparasitic agent is widely distributed to tissues and cells within the arthropod 
(Merzendorfer, 2013), suggesting that the whole body could be examined during kinetic studies 
of teflubenzuron in arthropods. 
 
1.6 TRANSCRIPTIONAL CHANGES AND OXIDATIVE STRESS 
When a gene is expressed in the nucleus of the cell, the base sequence (DNA) is copied by RNA 
polymerase to a molecule of pre messenger-RNA (mRNA), before it is spliced to the mature 
RNA in a process involving removal of the non-coding sequences introns. The first step in gene-
expression (Figure 1.6.1) where the base sequence is copied to the RNA, is transcription of 
genes (NCBI, 2014). This step is essential for the translation of the encoded genes (exons) into 
proteins in ribosomes. Since it is relatively easy to measure the levels of mRNA in cells, 
transcriptional changes have often been used as biomarkers of exposure or effect in animals 
exposed to stress, environmental change or contaminants. Changes at the transcriptional level 
due to exposure to antiparasitic agents can lead to an increased expression of various genes, and 
provides important knowledge for the understanding of biological processes. In this thesis, 13 
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Figure 1.6.1 Gene expression: the pathway from DNA to protein. The genomic DNA is transcribed, spliced and 
translated for the synthesis of proteins to occur. This figure is obtained from the National Center for Biotechnology 
Information (NCBI). 
 
1.6.1 DETOXIFICATION GENES 
The detoxification processes in cells involves activation of several defence regulators. The 
information about the defence mechanism in shrimps are limited, hence the information given 
will concern insects and crustacean in general. However, studies on elimination of toxicants in 
shrimps assume that enzymes like the cytochrome 3A (CYP3A) is an important regulator of 
detoxification processes in cells (James and Boyle, 1998). Cytochrome P450 are a family of 
heme proteins catalysing the oxidative metabolism of many chemicals within the lipophilic 
membrane of the endoplasmic reticulum (Gates, 2017). The proteins are often used as 
biomarkers in environmental toxicology studies, mostly because they are sensitive to stress and 
are easily induced. Studies have shown that the CYP3A subfamily proteins play an important 
part in the metabolism of xenobiotics in fish (Ku et al., 2014). Glutathione-S-transferase Mu 3 
(GSTM3) is known to be involved in detoxification processes in humans, and belongs to a 
group of glutathione-S-transferases (GST) responsible for phase II biotransformation in drug 
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metabolism and detoxifying of electrophilic substances. Three different classes of the GST 
enzymes are identified in insects, crustacean and humans, based on their location in cell. The 
GSTM3 enzymes are located in the cytosol and belongs to the mu class found in humans 
(Roncalli et al., 2015). In humans, the GSTM3 enzymes play a crucial role in detoxification 
and conjugation of toxins. The gene-expression of GSTM3 can be affected by DNA injury, 
leading to methylation of GST which reduce the expression rate of GSTM3, and can therefore 
be an indication of DNA damage (Qi et al., 2012). 
 
1.6.2 GENERAL STRESS 
When exposed to toxic substances, unfolded proteins trigger heat shock responses, which can 
lead to cell damage as defects in the cytoskeleton, fragmentation and dissembling of organelles, 
and changes in membrane morphology (Richter et al., 2010; Toivola et al., 2010). The RNA 
splicing is also affected by heat shock responses, when stress granulates in cytosol, containing 
non-translation mRNA, interfere with the transcriptions of genes (Buchan and Parker, 2009; 
Richter et al., 2010).  In response to these changes, the synthesis of heat shock proteins, or stress 
proteins is carried out (Richter et al., 2010). Among the stress proteins, heat shock protein-70 
(HSP70) is often used as a biomarker, including in crustaceans, as it might be strongly induced 
during stress (Ahamed et al., 2010). The HSP70 belongs to a family of heat shock proteins, and 
are located in the cytosol and in organelles like the mitochondria and the endoplasmic reticulum 
(Richter et al., 2010). Under stressful condition the HSP70 proteins are activated to inhibit the 













Figure 1.6.2.1: Cell structure. The endoplasmic reticulum (ER) and the mitochondria are a part of the cytosol 
surrounding the nucleus in the cell. Many proteins involved in detoxification and defence mechanism, like the 
hsp70, are located in the ER, mitochondria or other organelles in the cytosol. The Figure is obtained from: 
https://studyfaq.com/blog/animal-cell-anatomy-and-structure. 
Accumulation of misfolded proteins, or other factors like exposure of xenobiotic and increased 
ROS activity, can lead to cell apoptosis (cell death) (Menze et al., 2010). Cell apoptosis is highly 
regulated by enzymes and the mitochondria plays an important part of signalling apoptosis 
when cellular stress occurs. Enzymes of the B-cell lymphoma 2 (BCL-2) protein family 
regulates the traffic across the outer mitochondrial membrane (OMM), and upon apoptosis, the 
permeability of OMM increases. The increased permeability leads to a release of pro-apoptotic 
proteins from the mitochondria. Seven proteins of the BCL-2 family have been identified in 
crustaceans, but within the crustacean clan, there seems to be a high amount of diversity in 
BCL-2 proteins (Menze et al., 2010). A member of the BCL-2 protein family, the BCL-2 related 
protein (BCLX) is located in the mitochondrial membrane and ER, and belongs to antiapoptotic 
proteins within the family. Overexpression of BCLX affects the transmission of Ca2+ between 
mitochondria and endoplasmic reticulum by reducing the content of Ca2+ in endoplasmic 
reticulum, which make the cell more resistant to apoptosis. An increase of calcium on the other 





1.6.3 CHITIN SYNTHESIS 
Teflubenzuron is known to inhibit the chitin synthesis in crustaceans, but the mechanism is still 
unclear.  Some studies have claimed that benzoylureas inhibit chitin synthase during moulting 
(Langford et al., 2011), whereas some studies indicate that benzoylureas acts by inhibiting the 
conversion of chitin synthase into its active form (Leighton et al., 1981). In either way, 
teflubenzuron inhibit the biosynthesis for chitin, and the pathway was first characterized in 
insects. In 1962, a synthesis mechanism was proposed by Candy and Kilby, starting with 
glucose, and ending with UDP-N-acetylglucosamine (UDP-Glnac), before the final step from 
UDP-Glnac to chitin was established by Jarowski et al. in 1965 (Merzendorfer and Zimoch, 
2003). Today, a common biosynthesis pathway for insects, fungi and crustaceans is known, and 
can be seen in Figure 1.6.3.1. The first step is to convert glucose into a polymer N-
acetylglucosamine-6-P (GlcNac-6-P) and changing position of phosphate from C-6, to C-1 to 
form N-acetylglucosamine-1-P (GlcNac-1-P). GlcNac-1-P is then urinylated by UDP-GlcNAc 
pyrophoshorylase yielding UDP-N-Acetylglucosamine (UDP-GlcNAc). UDP-GlcNAc serves 
as a sugar donor to the growing chitin chain. The last reaction, polymerization of chitin is 
catalysed by chitin synthase. As can be seen from this pathway, chitin can also be reused in the 
new exoskeleton. When shrimps cast their exoskeleton, the old skeleton is often digested to 
recover minerals used in the new exoskeleton. Many enzymes are involved at different stages 
of this process, like chitinase (CHIT1A) which are responsible for the degradation of chitin to 
N-Acetylglucosamine (Figure 1.6.3.1) (Merzendorfer, 2011) and the chitobiase (CTBS). Both 
enzymes can be found in the moulting fluid, secreted by the epidermis. In addition to the 
epidermis, CTBS is also present in digestive juice secreted by hepatopancreas, and the activity 
of CTBS is higher in the pre-moulting phase (Zou and Fingerman, 1999). Several steps of 
degradation are required before chitin is reabsorbed into the new cuticle (Avila et al., 2011). 
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Figure 1.6.3.1: The synthesis of chitin. The enzyme studied in this thesis is marked with a red border. The figure 
is obtained from a report by Metabolon on global metabolic profiling data for NIFES. 
 
1.6.4 OXIDATIVE STRESS 
Reactive oxygen species (ROS) is the collective term of free radicals and reactive molecules 
produced during ordinary aerobic metabolism. Within the ROS term, there are several 
molecules having different chemical properties and biological activities. It is important to keep 
a low level of ROS in cells, as some of these species influence cellular signalling (Figure 
1.6.4.1), and can cause oxidation of lipids, proteins and DNA. Superoxide anion (O2•
-) and 
hydrogen peroxide (H2O2) are ROS affecting cellular signalling and the main source for 
production of these ROS are the mitochondria and the family of NADPH oxidases (NOXs).  
O2•
- is produced through a one-electron reduction of O2. In order to maintain a low level of 
ROS, the body has established an antioxidative defence (Glasauer and Chandel, 2013). 
However, when the balance between pro-oxidants and antioxidants is interrupted, favouring the 
oxidants, a condition called oxidative stress occur. This unbalance can cause an increased ROS 
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production or damage to the antioxidative defence (Qiu et al., 2011; Shao et al., 2012). 
Prolonged oxidative stress can lead to DNA damage, pathological changes in tissue and 
dysfunction in the body (Li et al., 2016).  
 
Figure 1.6.4.1: Cellular signalling can be affected by ROS released from mitochondria and enzymes of the 
NADPH family (NOXs). Mitochondria can either release O2*-, (being convert to H2O2 in cytosol by SOD1) or 
H2O2 directly in cytosol. H2O2 control cell signalling trough thiol oxidation within proteins, and the level of H2O2 
determinates the input on homeostasis and adaption to stress. The figure is obtained from the journal article of 
Glasauer and Chandel (2013). 
An increase in ROS can be induce by environmental changes, or by contaminates, like 
teflubenzuron. Increased ROS formation can occur both directly (contaminant stimulate ROS 
production) or indirectly (contaminant cause tissue injury leading to release of ROS). There are 
a great variety of mechanism increasing ROS formation during oxidative stress. When 
teflubenzuron, or any other organic lipophilic compound is accumulated, it can stimulate ROS 
production by disturbing electron transport systems e.g. in mitochondria and ER (Livingstone, 
2001). 
In crustacean, the antioxidant defence against ROS consist of a variety of enzymatic and non-
enzymatic agents like the superoxide dismutase (SOD), catalase (CAT), Se-glutathione 
peroxidase (GPX), gluthatione synthease (GSS) and glutamate-cysteine ligase catalytic subunit 
(GCLC). The two latter enzymes regulate the levels of glutathion (GSH), an important cellular 
antioxidant protecting cells by maintaining the thiol groups in proteins, regulating the protein 
function after translation and detoxification of xenobiotics (Nichenametla et al., 2011). The 
antioxidant (GSH) is produced within the cell, and has the advantage of reacting with both oxide 
and hydroxyl radicals, leaving water as the waste product (Cole et al., 2011; Thorstensen, 2014). 
As shown in Figure 1.6.4.2, glutathione peroxidase (GPX) utilize 2 GSH to turn hydrogen 
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peroxide with the help of Se into oxidized glutathione (GSSG) and water. Catalase also has a 
role in catabolizing hydrogen peroxide, in peroxisomes. As can be seen in Figure 1.6.4.1, the 
SOD-enzymes are responsible for the conversion of superoxide anions (O2•
-) into hydrogen 
peroxide (H2O2) (Shao et al., 2012). In cytosol, the zink-SOD (Zn-SOD) is responsible for this 
transformation, while manganese-SOD (Mn-SOD) is responsible in the mitochondria (Lubos et 
al., 2011; Thorstensen, 2014). Comparison studies regarding some of these antioxidative 
enzymes have shown a lower GPX activity in invertebrates in contrast to vertebrates, while the 
CAT and SOD activities were similar or higher. This may suggest that CAT and SOD plays an 








Figure 1.6.4.2: The catabolism of hydrogen peroxide by glutathione peroxidase. The figure is obtained from 
http://www.robertbarrington.net/wp-content/uploads/2014/01/Glutathione-Metabolism.png. 
 
1.6.5 PROTEIN CARBONYL AND LIPID PEROXIDATION 
The method of measuring content of protein carbonyl is one of the most common for 
determining protein oxidation. The formation of protein carbonyl occurs when ROS attacking 
the side-chains of proteins leading to an oxidation of amino acids residues and backbone. 
Derivate of protein carbonyl can also occur indirectly through oxidative cleavage of proteins, 
or by a secondary reaction of nucleophilic side chains of amino acid with reactive carbonyl 
compounds like aldehyde or ketone (Dalle-Donne et al., 2003; Kolgiri and Patil, 2017). Protein 
carbonyls are chemically stable and many commercial assays are available. However, the level 
of protein carbonyl in different tissues can vary depending on the assay used (Dalle-Donne et 
al., 2003). Determination of malondialdehyd (MDA) is also used to measure oxidative stress. 
MDA is the product of lipid peroxidation when polyunsaturated lipids are attacked by ROS, 
and can react with side chains of amino acid to form protein carbonyl. MDA reacts with 
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thiobarbituric acid at high temperature, and produce a red malondialdehyde-thiobarbuturic acid 
product and the absorbance can be measure by a spectrophotometer (Qiu et al., 2011). 
 
1.7 PINK SHRIMPS 
According to Langford et al. (2014), only minor concentrations of teflubenzuron were found in 
deep-water shrimps caught 1-5 km from a farm where treatment with teflubenzuron had 
occurred less than a month ago. Pink shrimp lives closer to the shore, at 4-700 m depth, and is 
commonly observed between 100 and 200 m depth. As the farming pens often are located close 
to the shore, pink shrimps are more exposed to chemical substances used in salmonid farms.  
Therefore, pink shrimps (Pandalus montagui) were studied in this thesis. The pink shrimp 
belong to the order Decopoda, and like other shrimps they undergo moulting several times 
during their lifecycle (Britannica, 2017). The pink shrimp is characterized  by their semi-
transparent pink/brown appearance and the shape of the rostrum witch is slightly bend upward 
(Ruiz, 2008). The shrimps are located in northern Atlantic, Canada, The British isles and the 

















1.8 THE AIM OF THIS STUDY 
The main aim of this study was to examine pharmacokinetics and transcriptional 
changes/oxidative stress in pink shrimps exposed to teflubenzuron.  
The pharmacokinetic aspect involved examination of uptake and accumulation of teflubenzuron 
during the feeding trial, while the oxidative stress analyses gained insight into the mechanistic 
effect of the antiparasitic compound. A few molecular markers for detoxification, cellular stress 
and exoskeleton change were also studied.   
The results of the current study will be useful for the evaluation of effects of teflubenzuron on 





















2. MATERIALS AND METHODS  
The methodological description in this thesis will be divided into three parts. The first part 
describes the pharmacokinetic studies carried out at the Contaminants laboratory at NIFES, 
whereas the second and third parts describe gene-expression analyses and oxidative stress 
assays preformed at the Molecular Biology laboratory at NIFES. 
2.1 THE FEEDING EXPERIMENT 
In this experiment, 52 pink shrimps (Pandalus montagui) from Hjeltefjorden, in Hordaland, 
were placed in individual cages (Figure 2.1.1) in three different tanks at the Matre Research 
Station, Institute of Marine Research (IMR), Norway.  The acclimation period was set to 14 
days. The shrimps were fed two times per week, Monday and Thursday, for forty-six days. The 
pellets were 3 mm and contained either no teflubenzuron, a low dose of 0.01 µg/g pellets or a 
high dose of 0.1 µg/g teflubenzuron per pellets. To prepare the given doses of teflubenzuron in 
the diet, a 1 mg/g mix (mix-1) was made of 10 mg teflubenzuron and 10 g glucose. The total 
amount of pellets per group was calculated to be approximately 1200 pellets ≈ 144 g pellets.  
The amount of teflubenzuron per pellet was calculated to be 0.44 µg in the high dose group, 
and 0.044 µg in the low group, which gives a total of 528 µg (high dose) and 52.8 µg (low dose) 
teflubenzuron to coat on 144 g pellets. A full description of how the two doses (528 µg and 
52.8 µg) was prepared from the 1 mg/g mix can be obtained from Appendix 1. To lace the drug 
to the surface of the feeding pellets, cod-liver oil (Møllers, Orkla health) was used for both 
doses. The percentage of the concentration given in Figure 2.1.2 shows the amount of 







Figure 2.1.1: (A and B) the tanks and cages used in the feeding experiment at the Matre Research Station. (C) The 





At the end of the experiment at Matre April 4, 2016 the size of the pink shrimps was record as 
carapace length (CL) and total weight (g). The carapace length is the part of the shrimps that 
cover the back part of the head/breast piece (Figure 2.1.1). As the total length of shrimps is 
difficult to measure because of the tale/back part shape, CL is the most common way to measure 
length in crustaceans. Of the 52 pink shrimps originally used in this experiment, five shrimps 
were found dead in their cages at the end of the feeding trial. The remaining 47 shrimps had an 
average CL at 14 mm, and total weight of 2.39 g. Surviving shrimps after 46 days of feeding 
were examined for deformities. The shrimps were then killed by freezing in liquid nitrogen and 
stored at – 80°C at the molecular lab at NIFES. At NIFES, the shrimps were homogenized with 
mortar and pistil on dry ice to avoid damaging the RNA. All equipment used for homogenizing 
where cleaned with RNase zap™ (Sigma-Aldrich) to reduce contamination. After 
homogenizing, tissue samples were stored at – 80°C. Some tissue samples were aliquoted for 
chemical analysis in the Contaminants laboratory, and these samples were stored at -20°C. 
 
 
             100%                             0%                               0.1%                                1% 
 
 
Figure 2.1.2: Concentration of teflubenzuron given in the feeding experiment at Matre Reseach Station, Institute 
of Marine Reseach, in Norway given as percentage of normal fish therapy dose given daily to salmons affected by 
lice. N gives the number of shrimps in each group.  
 
Extra shrimps  
Several additional pink shrimps were obtained from IMR September 8, 2016. Twenty of these 
shrimps, with an average CL of 15.56 mm and total weight of 3.095 g, were killed in liquid 
nitrogen and stored at - 80°C.  The same homogenizing procedure was performed on these 
shrimps as for the pink shrimps from Matre Research Station. These shrimps were not a part of 
the feeding experiment, and the purpose with these shrimps was mainly for testing of new kits. 
However, as the controls from the feeding experiment contained teflubenzuron above LOQ, the 
additional shrimps were used as extra controls in all analyses. In this work, the additional 
shrimps are presented as extra controls. 
Control-group 
n = 15 
Dose B: 
0,01 µg/g pellet 
n=17 
Dose A:  




2.2 PHARMACOKINETIC ANALYSIS 
For the pharmacokinetic analysis, a method developed by NIFES for quantitative determination 
of diflubenzuron and teflubenzuron in seafood was used. Tissue was aliquoted from the whole 
animal, and the amount measured before starting this assay.  
 
2.2.1 CHEMICALS 
Teflubenzuron (analytical standard), diflubenzuron (analytical standard), diflubenzuron-d4 
(analytical standard), acetonitrile, heptane, diethyl ether and acetone (all HPLC grade) were 
purchased from Sigma–Aldrich (Steinheim, Germany). Tetrahydrofuran (HPLC grade) and 
ammonium hydroxide (25%) (PA grade) were purchased from Merck (Darmstadt, Germany). 
The water used was purified with a Milli-Q water purification system from Millipore. 
 
2.2.2 STOCK SOLUTION AND WORKING SOLUTIONS  
Five stock solutions were already prepared before chemical analysis. To prepare the stock 
solutions and the working solutions, same procedure as describe in the work by Erdal (Erdal, 
2012) was performed with just a few modification.  In this work, five stock solutions were 
prepared, one for internal standard (IS), two for diflubenzuron (control and standard curve) and 
two for teflubenzuron (control and standard curve).  From these stocks solutions, two working 
solutions was made, one for the controls and one for the standard curve. To prepare the stock 
solutions, 10.00 mg ± 0.04 mg of the substance was add to a vial and diluted with 
tetrahydrofuran to a concentration of 1 mg/mL.  To prepare the working solutions, 50 µL of 
teflubenzuron and 50 µL diflubenzuron from each stock solutions were mixed before diluting 
with acetonitrile: water (1:1) to 10 mL, giving a concentration of 5 µg/mL. Thereafter 100 µL 
of the diluted solution was further diluted with acetonitrile: water (1:1) to 10 mL, giving a final 
concentration of 50 ng/mL. Diflubenzuron  was only included in this analyse due to being a 
part of the original method.  
 
2.2.3 PREPARATION/SPIKING OF SAMPLES 
Approximately 0.5 g (Appendix 2) was aliquoted from tissue samples and then transferred into 
15 mL falcon-tubes, and stored at -20°C.  In addition to the pink shrimp samples, 9 samples 
from the extra shrimps, 5 controls, a blank sample with matrix from shrimp and a blank sample 
without matrix were included. For all the samples, a 9-point calibration curve was set, marked 
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N1-9. N1-N6 were spike with 20, 80,200,400,600 and 800 µL of standard solution (teflubenzuron 
/ diflubenzuron 50 ng/mL), while N7-N9 were spike with 10, 20 and 30 µL of the mid-solution 
(5 µg/mL teflubenzuron / diflubenzuron) made during dilution preparation. For validation, one 
control (K1) was spike at LOQ level (1 ng/g), while the rest of the controls were spike at 10 
ng/g (K2, 3 parallels) and 100 ng/g (K3). Diflubenzuron-d4 was used as internal standard (IS), 
and stock solutions with diflubenzuron were included in this method. All the samples were 
added 200 µL IS (50 ng/mL diflubenzuron -d4 solution). 
 
2.2.4 EXTRACTION AND DETERMINATION OF TEFLUBENZURON IN SHRIMPS 
Teflubenzuron, diflubenzuron and IS were extracted from the sample matrixes by dissolving 
each sample in 5 mL acetone, before shaken on whirl mixer for 1 min. Afterward the samples 
were placed in ultrasonic bath for 10 min. and then centrifuged (Eppendorf centrifuge 5810 
Hamburg, Germany), for 3 min. at 3220 g.  
The supernatants were transferred to 10 mL centrifuge tubes, before steaming dry with nitrogen 
gas (cleanness ≥ 99.995) at 40°C.  The dried samples were dissolve in 5 mL heptane and 
carefully shaken on whirl mixer before they were transferred to 20 mL Automated Solid Phase 
extraction (ASPEC) tubes.  The samples were purified by solid phase extraction on ASPEC 
GX-274 (Gilson, Middleton, USA). At first, the silica-column was conditioned with 2.5 mL 
heptane prior to loading the sample. Afterwards, the column was washed with 3 mL of heptane 
before washing with 5 mL diethyl-ether/heptane (5:95) and 5 mL diethyl-ether/heptane (10:90). 
At the end, the analytes were eluted with 5 mL diethyl-ether/heptane (40:60) before evaporated 
to dryness using nitrogen gas. Thereafter the analytes were dissolved in 250 µL acetone nitrile 
/water (75:25). The samples were filtered through a 0.45µm syringe filter and transfer to a 2.0 
mL HPLC vial before analysing with LC-MS/MS. 
 
3.2.5 LC-MS/MS (QQQ) 
LC-MS/MS is a selective and sensitive instrument using the benefits of liquid chromatography 
(LC) to separate the compounds, and triple quadrupole mass spectrometry (MS/MS) to detect 
and measure the concentration. When preforming LC, high pressure is used to force a solvent 
through a column containing a stationary phase. Throughout the column the molecules are 
separated by speed (retention time) due to their affinity to the stationary phase. Detection with 
mass-spectrometry (MS) on the other hand, uses mass-to-charge ratio of ionized molecule to 
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distinguish molecules. To give a mass spectrum, the molecules are first ionized, and then 
accelerated by an electronic or a magnetic field, before being separate by mass charge ratio 
(m/z)(Harris, 2010).  
To analyse teflubenzuron, the LC-MS/MS was carried out using a HP 1200 LC-system 
(Hewlett-Packard, Waldbronn, Germany) couplet to an Agilent 6460 triple quadrupole mass 
spectrometer (Agilent technologies, Waldbronn, Germany). Masshunter software (Agilent 
Technologies) was used for data treatment. The injection volume was 2 µL, and a solution of                 
acetonitrile (75%) and purified water (25%) was used as mobile phase with a flow rate of 0.4 
mL/min at room temperature. The retention time for teflubenzuron was 0.83 min, and 0.55 min 
for IS. Agilent Jet Stream negative electrospray (AJS ESI) was used to ionize the liquid at the 
interface, and multiple reaction monitoring (MRM) was used to detect the analytes. The mass 
to charge ratio (m/z) was 379.0/339.0 for teflubenzuron quantifier transition, 379.0/195.9 for 
teflubenzuron qualifier transition and 313.0/ 293.1 for IS (Appendix 2). Furthermore, these 
parameters were used: drying gas temperature: 300°C; gas flow: 5 L/min; nebulizer pressure: 
45 psi; sheet gas heater: 250°C; sheat gas flow: 11 L/min; Capillary voltage: 3500 V and 
charging voltage: 500 V.  Level of quantitative (LOQ) was set to 0.2 ng/g. The method was 














2.3. GENE-EXPRESSION ANALYSES  
For the gene-expression analyses, RNA was isolated from the shrimp tissue, and the quality and 
integrity were controlled, before the RNA was synthesised to cDNA. Two cDNA plates were 
prepared, and the primers were run at RT-qPCR.  All potential primers were tested with One-
Step PCR, followed by gel-electrophoresis. All materials and kits used in these analyses are 
listed in Table 2.3.1 and Table 2.3.2. Materials and kits used for the colorimetric analyses to 
measure content of protein carbonyl and malondialdehyde (MDA) in the tissue-samples are also 
included in the table. 
 
Table 2.3.1:  Materials used in the gene-expression analyses and the colorimetric analyses. 
Chemical/reagens Supplier/product no. Method 
Purified water from Milli-Q water 
system 
Millipore all 
Chloroform Sigma-Aldrich  
Cat. No 1731042 
RNA-isolation 
QIAzol Lysis Reagents Qiagen cat. No 79306 RNA-isolation 
RNase Zap™ Sigma-Aldrich no R2020 RNA-isolation 
TagMan® reverse transcription 
reagens  kit 
TaqMan RT buffer 10X 
25mM magnesium chloride 
Deoxy NTPs 
RNase inhibitor 
Multiscribe reverse transcriptase 
(50U/µL)  
Applied Biosystems  




LightCycler® 480 SYBRGreen 
master 
Roche Applied Science 
No. 4887352001 
RT-qPCR preparation 
OneStep RT-PCR kit 
5x Qiagen One Step RT-PCR buffer 
5x Q-solution 
dNTP mix  
Qiagen No 210212 OneStep RT-PCR 
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Qiagen One Step RT-PCR Enzyme 
mix 
RNase inhibitor Applied Biosystems (RT 
reaction kit)  
Item no N8080234 
OneStep RT-PCR 
TE buffer (1X) PH8 PanReac Applichem  
Item no A2575 
Diluting primers 
Utra Pure™Agarose  Invitrogen  
Item no. 0000419824 
Electrophorese 
TAE buffer 50 x BioRad cat. No 161-0773 Electrophorese 
Gel Red™ nucleic Acid Strain Qiagen no 130175937 Electrophorese 
Gel pilot loading gel x5 Qiagen no.142324491 Electrophorese 
Gel pilot 50 bp ladder  Qiagen no 1036712 Electrophorese 
Protein carbonyl colorimetric Assay 
kit  
12M Hydrochloric acid 
2,4-dintrophenylhydrazine (DNPH) 












Measure content of protein 
carbonyl  
Phosphate buffered saline tablet Sigma-Aldrich 
No. P4417 
Protein carbonyl 
colorimetric Assay kit 
1mM EDTA Sigma-Aldrich  
Cat. No 03680 
Protein carbonyl 
colorimetric Assay kit 
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Lipid peroxidation (MDA) assay kit 










Measure content of MDA 
Glacial acetic acid Merck No. 100063 Measure content of MDA 
 
 
Table 2.3.2: Kits used in the gene-expression analyses and the colorimetric analyses. 
Kit Description Supplier/product no. 
EZ1 RNA universal tissue kit Isolate RNA from tissue Qiagen, no. 956034  
RNA 6000 Nano LabChip 
Kit 
Check integrity of RNA Agilent Technologies 
TaqMan® reverse 
transcription reagens kit 
Make cDNA out of RNA Applied Biosystems  
Item no. N808 0234 
OneStep RT-PCR kit Checking primers for qPCR Qiagen cat. No 210212 
Protein carbonyl colorimetric 
assay 
Measure content of protein 
carbonyl  


















When analysing gene-expression, the first step is isolation of RNA from tissue.  For mRNA 
analyses, it is of crucial importance to isolate high quality RNA, as leftovers of proteins and 
DNA can interfere with reagents or samples during preparation and measurements. For the pink 
shrimp tissue, a method for purification of RNA using an EZ1 Bio robot (Qiagen) and liquid-
liquid extraction with guanidinium salt-phenol solution and chloroform was used. Due to the 
reaction with phenol and chloroform, a phase separation occurs as DNA and proteins fractionate 
into a phenol phase at the bottom of the vial, leaving RNA in an aqueous phase at top. 
Guanidium salts are added with phenol to minimize cleavage of nucleic acids during reaction 
(Zumbo, 2012). After separation, the RNA is further purified at the EZ1-robot, where the RNA 
is bound to magnetic beads during time run, and eluted by water at the end.   
 
At first, 750 µL QIAzol lysis reagent and 4 pellets were added to a 2 mL tube suitable for 
homogenizing. The tissues (about 60-80 mg) were transfer to the tubes and homogenized at 
6000 rpm, 3 x 15s (precellys 24, Bertin technologies), before incubating for 5 min. at room 
temperature.  Afterwards, 150 µL chloroform was added. The samples were shaken for 15 s 
and incubated for another 2-3 min. before centrifuging for 15 min, 12 000 g at 4°C (Centrifuge 
5415, Eppendorf, Hamburg, Germany). While the samples were centrifuged, DNase was 
thawed on ice, before 10 µL was add to each reagent cartridges to digest and remove DNA 
contamination in the samples. The elution tube (1.5 mL), sample tube (2 mL), disposable filter 
tips and disposable tip holders were prepared according to the protocol for EZ1 RNA universal 
tissue kit (Qiagen). The upper layer containing RNA was transfer to the sample tubes before 
running EZ1. The samples were put on ice afterwards.  
 
2.3.2 QUALITY CHECK 
The concentration and purity of RNA were measured with the NanoDrop® ND1000 (Termo 
Fisher Scientific, Wilmington, USA) according to the manufacturer’s protocol. To check the 
integrity of the RNA, the Bioanalyzer 2100 and the RNA 6000 Nano LabChip Kit (Agilent 
Technologies, Santa Clara, USA) were used according to the manufacturer’s protocol.  All 
samples were run simultaneously (twelve per chip), chosen randomly from the samples from 





2.3.3 RT-REACTION (REVERSE TRANSCRIPTASE REACTION) 
For the synthesis of cDNA from RNA, TaqMan® Reverse Transcription Reagents kit (Applied 
Biosystems, Thermo Fisher Scientific, Waltham, USA) was use, and the procedure was 
performed according to manufacturer’s protocol to a final reaction volume of 50 µL. The RNA 
samples were thawed on ice before the needed amounts (2.40-26.49 µL) to make a 50 ng/µL ( 
±5%) dilution with ddH2O were transferred into new tubes and diluted.  
A standard curve containing RNA from all samples was made as shown in Figure 2.3.3.1.  
    A    40 µL   B   40 µL   C   40 µL   D   40 µL    E   40 µL   F           
  
                                                                                                   + 40 µL ddH2O in tube B-F 
100 ng/µL    50 ng/µL   25 ng/µL    12.5 ng/µL   6.25 ng/µL   3.125 ng/µL 
Figure 2.3.3.1: The diluted standard curve with the concentrations 100 ng/µL, 50 ng/µL, 25 ng/µL, 12.5 ng/µL, 
6.25 ng/µL and 3.125 ng/µL. Tube B-E were first diluted with 40µL ddH2O before transferring 40 µL of the 
mixture into the next tube. At the end, tube A-E had a total volume of 40 µL, while F had a total volume of 80 µL.   
 
Two cDNA plates were prepared, with the standard curve run in triplicates (for both plates), 
and samples run in triplicates (plate 1) and duplicates (plate 2) on a 96 well reaction plate. Each 
cDNA plate also contained two controls, a non-amplification control (nac) without enzymes 
and no-control template (ntc) without RNA. The setup for both cDNA plates can be seen in 
Figure 2.3.3.2 and 2.3.3.3. The reverse transcriptase mix (RT mix) without enzymes was 
prepared according to the manufactures guideline (Appendix 3) and 40 µL was added to the nac 
well, before adding enzymes in the RT mix and distribute to the rest of the wells. In addition to 
the RT mix, 10 µL of diluted RNA was add to each well, except or the ntc and nac well. In the 
nac well, 10 µL of diluted RNA mix with similar concentration was add, and for the ntc well, 
the remaining 10 µL was fill with ddH20, given a total of 50 µL in each well. The plate was 
centrifuged at 50 g (centrifuge 5810, Eppendorf, Hamburg, Germany ) for some seconds, and 
RT reaction was performed at the PCR machine, Gene Amp PCR System 9700 (Applied 






1 2 3 4 5 6 7 8 9 10 11 12 
A std1 std1 std1 std2 std2 std2 std3 std3 std3 std4 std4 std4 
  1000 ng 1000 ng 1000 ng 500ng 500ng 500ng 250ng 250ng 250ng 125ng 125ng 125ng 
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529/25   nac ntc 
  500ng 500ng 500ng 500ng 500ng 500ng 500ng 500ng 500ng       
 
Figure 2.3.3.2: c-DNA plate 1 with samples 1-25 (controls and low dose) run in triplicates. Nac is without enzyme, 












1 2 3 4 5 6 7 8 9 10 11 12 
A std1 std1 std1 std2 std2 std2 std3 std3 std3 std4 std4 std4 
  1000 ng 1000 ng 1000 ng 500ng 500ng 500ng 250ng 250ng 250ng 125ng 125ng 125ng 
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529/46 nac ntc 
  500ng 500ng 500ng 500ng 500ng 500ng 500ng 500ng 500ng 500ng     
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Figure 2.3.3.3: c-DNA plate 2 with samples 26-33, 35,37-43,45-48,50-51 (low dose and high dose) + 1-9 (extra 










2.3.4 REAL TIME QUANTITATIVE POLYMERASE CHAIN REACTION (RT-QPCR) 
RT-qPCR is a method used to quantify small nucleic acids from a single or double stranded 
DNA template when comparing gene expression from different tissues. The principle of PCR 
is to synthesize a new strand complementary to the DNA template with a heat-stable 
polymerase. Two primers (with similar melting temperature) have to anneal each 
complimentary template before the polymerase can extend the primers into a new strand by 
using dNTPs (four nucleotides of DNA) as building blocks. The method is based on a heat 
cycle, as high temperature (95°C) is required to separate the strands, before temperature is 
lowered for the annealing of primers to occur. The elongation step (extension of primer) is often 
set to 60-72°C, depending on the method used. A fluorescent reporter is also required to bind 
to the products and report by fluorescence the amount of product produced during reaction  
(Kubista et al., 2006). In the procedure used for this thesis, SYBR Green dyes was use as a 
fluorescent reporter.  
Moreover, 3 or more endogenous controls (reference gene) are often necessary to normalize for 
variation between samples and correct for errors in sample preparation (Derveaux et al., 2010). 
For teflubenzuron in shrimps actb,uba52, ef1a and rpl13 were selected as potential reference 
genes and the program GeNorm v.3.5 was used to determine the stability of the reference gene 
and to calculate a normalization factor, M (Vandesompele et al., 2002)  
In addition to the four references genes, 13 genes were quantified with RT-qPCR. Primer 
Express 2.0 software (Applied Biosystems,Foster City, USA) was used to select appropriate 
primers form the sequenced shrimp gene. Exon-exon borders were not considered when making 
the PCR primers due to lack of genomic information. A transcriptome made from whole-shrimp 
RNA (from both control and exposed shrimp) was sequenced and assembled with Illumina 
paired-end read (PE150) to search for target genes. The sequencing was prepared by using the 
NEBNext Ultra RNA library Prep Kit (Illumina, NEB, USA) according to the manufactory’s 
guideline. Contigs (overlapping DNA sequences defining a region of the genome) were 
annotated to the seven databases NR, NT, Swiss-Prot, KEGG, COG, GO and InterPro by using 
a BLAST cut of 105. The unassembled singletons were annotated using ESTcan employing 
default settings (Iseli et al., 1999). Similarity to previously examined gene sequences from 
experiments with dose-response effects of teflubenzuron exposure in transcripts in juvenile 
lobster (Olsvik et al., 2015), were examined by using Geneious Software (Biomatters, 
Auckland, New Zealand). 
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At first, the cDNA plates were thawed on ice, before centrifuging at 800 g (centrifuge 5810, 
Eppendorf, Hamburg, Germany) for one min. and vortex at 1500 rpm for 5 minutes (MixMate 
PCR96, Eppendorf, Hamburg, Germany). A two-fold dilution (50:50) of cDNA was performed 
by Biomak®4000 pipetting robot (Beckman Coulter, USA), before making the SYBRGreen 
reaction mix (Appendix 3) with the gene specific primers (500 nM of each).  Biomak®4000 
pipetting robot was further used to distributing 8 µL of the master mix and 2 µL of cDNA to a 
Lightcycler® 480 multiwell plate (384 well plate). Afterwards, the plates were spun down at 
1500 g for 2 min. before running on CFx384 touch™ Real-Time PCR Detection System (Bio-












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3.5 ONE STEP RT-PCR 
One Step RT-PCR is a method where the synthesis of cDNA from RNA and PCR occurs in 
same vial and is often used to test the integrity of potential primers with gel-electrophoresis, 
before RT-qPCR. Qiagen One Step RT-PCR kit was used in this work, and the method was 
performed according to the manufactures protocol. All primers were diluted with TE buffer to 
a concentration of 50 µM before starting this assay.  
All the non-enzymatic reagents were mixed and 0.2 mL was added to new vials, before adding 
the enzymes and the RNA. The mix was centrifuged (MiniStar Silverline, VWR, Vienna, 
Austria), and the RT-PCR reaction was performed following the program given in Appendix 3, 
at Gene Amp PCR System 9700 (Applied Biosystems, Foster city, USA). 
 
2.3.6 ELECTROPHORESIS WITH AGAROSE GEL 
Electrophoresis can be used to separate different fragments of DNA by size. The principle of 
this method is that negatively charged DNA will move towards a positively charged electrode, 
and the speed is dependent on size of the DNA fragments. Larger fragments will move slower 
than small fragment. The resistance in the gel also affects the speed of fragments, and higher 
density forces the fragments to move slower. Density of gel and the choice of ladder (fragments 
with known length) is selected by PCR-product size (number of base pair in DNA).  In this 
work, PCR products containing few base pair (100-150 bp) were use, and for this reason, a 
higher density agarose gel (2%) was prepared and a 50 bp ladder used. 
When preparing a 2% agarose gel, 3-gram agarose powder was measured and transferred to a 
500 mL Erlenmeyer flask. The powder was dissolved in 150 mL of 1xTE buffer under heat 
(microwave) and cooled before adding 15 µL Gel Red™ nucleic acid Strain. Gel Red™ nucleic 
acid Strain is added to visualize DNA under UV-light as it binds to the moving fragments. The 
agarose gel solution was poured into the casting vessel and bobbles were removed with the 15 
well comb. The comb is used to form wells in the gel. The agarose gel had to congeal before 
adding a primer mixture of loading buffer (2 µL) and PCR product (8 µL) for each primer, to 
the wells of the gel. A 6 µL ladder was added to the first well. After running electrophoresis, 





2.4. OXIDATIVE STRESS ASSAY 
2.4.1 PROTEIN CARBONYL COLORIMETRIC ASSAY KIT 
A kit from Cayman Chemical, product no. 10005020 was used for colorimetric measurements 
of protein carbonyl content. Protein carbonyls are aldehydes or ketones formed at the side 
chains of proteins after attack from free oxygen radicals, indicating oxidative stress (Dalle-
Donne et al., 2003).  All reagents, except for the phosphate saline buffer solutions were obtained 
from supplier. The two solutions, phosphate saline buffer and phosphate buffer with 1mM 
EDTA were prepared at the lab. For the phosphate buffer with 1mM EDTA, pH was adjusted 
to 6.7 with diluted 2.5 M hydrochloric acid. For the centrifuge, Eppendorf centrifuge 5810 
(Hamburg, Germany) was used. 
For preparation, homogenized tissue (200-300 mg) was aliquoted on dry ice and rinsed in 
phosphate saline buffered solution. Afterwards 1 mL of cold phosphate buffer containing 1mM 
EDTA was added before the samples were homogenized at 6000 rpm, 3 x 15s (Precellys 24, 
Bertin technologies) and centrifuged for 15 min., 10.000 g, at 4°C. The supernatant was then 
transferred to another vial to measure the absorbance ratio (280/260 nm) using the Nanodrop 
ND1000 with the homogenizing buffer as blank.  A ratio lower than 1 indicated contamination 
of nucleic acids.  
At first 200 µL of sample was transferred to 2 mL plastic tube, one for sample tube (S) and one 
for control tube (C). Then 800 µL of DNPH was added to the sample tubes, and 800 µL 2.5 M 
HCl was added to the control tubes, before vortexing and incubating in the dark for one hour. 
Every 15 min. during incubation, the samples were vortexed. After incubation, 1 mL of 20% 
TCA was added to the samples, vortexed and placed on ice for 5 min. Afterwards, the samples 
were centrifuged for 10 min., 10 000 g at 4°C, and the supernatants were discarded. The next 
step was to resuspend the pellets in 1 mL of 10% TCA, before the samples were vortexed and 
set on ice for another 5 min. The samples were centrifuged for 10 min., 10 000 g at 4°C, and 
the supernatant was discarded once more. For the washing step, 1 mL of ethyl acetate 1:1 
ethanol was used and these steps were repeated three times. At first, the ethyl acetate-ethanol 
mix was added to each sample, vortexed and centrifuged for 10 min., 10 000 g at 4°C before 
discarding the supernatant. The final step was to resuspend the protein pellet in 500 µL of 
guanidine hydrochloride, vortexed and centrifuged to remove any leftover debris. Then 220 µL 
of supernatant of the S tube was transferred to two wells of the 96 well plate, and 220 µL of 
supernatant of the C tube to another two wells of the 96 well plate. The absorbance (at 380 nm) 
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was measured at a Victor x5 (Perkin Elmer, Waltham, MA) spectrophotometer, before the 
concentration was calculated according to the manufactures guideline. 
 
2.4.2 LIPID PEROXIDATION (MDA) 
Malondialdehyd (MDA) is the main product of the reaction when lipids are oxidized, and the 
content of MDA can be measured as an indication of oxidative stress (Qiu et al., 2011).  All the 
reagents, except from the glacial acetic acid, were supplied in the lipid peroxidation (MDA) kit 
from Sigma Aldrich, Catalogue no. MAK085. In this assay, MDA concentration is determinate 
by colorimetric analysis. For the centrifuge, Eppendorf centrifuge 5810 (Hamburg, Germany) 
was used. 
At first, all the samples were thawed at room temperature. The TBA solution was made by 
reconstituting a bottle with TBA powder with 7.5 mL glacial acetic acid before bringing the 
volume to 25 mL with purified water. After that, the aliquoted tissue (about 10 mg) was put on 
ice and 300 µL of MDA lysis buffer with 3 µL of BHT (100x) was added before homogenizing 
at  6000 rpm, 2 x 15s (Precellys 24, Bertin technologies) Then the samples were centrifuged at 
13 000 g for 10 min. and the pellets discharged. Meanwhile, the MDA standards for 
colorimetric detection were prepared by diluting 4.17 M MDA standard with 980 µL of water 
to make a 0.1 M MDA standard solution, of which 20 mL was further diluted with 980 µL to 
get a 0.2 mM standard.  From the 0.2 mM solution 0, 2, 4, 6, 8 and 10 µL were transferred into 
separate micro centrifuge tubes, generating 0 (blank), 4, 8, 12, 16 and 20 nM standards by 
diluting with ddH2O to a final volume of 200 mL. Afterwards, 600 µL of the TBA solution was 
add to each vial containing standards and samples to form a MDA-TBA adduct. Then the 
samples were incubated at 95°C for 60 min. After incubation, the samples were placed on ice 
and cooled to room temperature for 10 min. From the reacting mixture, 200 µL was pipetted 
into a 96 well plate and analysed (532 nm) at a Victor x5 (Perkinelmer, Waltham, MA) 








3.1 STATISTICAL ANALYSIS 
The statistical analyses for this thesis were performed in GraphPad Prism 7.02 software 
(GraphPad Software Inc, San Diego, CA, USA 2017). In GraphPad Prims 7.02 one-way 
analysis of variance (one-way ANOVA) with Holm-Sidak’s multiple comparison test  was used 
to compare the means of accumulated teflubenzuron, CL and weight in all treatment groups, 
and to compare the mean normalized expression (MNE) of the transcripts between the groups. 
In cases where the Bartlett and Brown Forsyth’s test showed a significant difference (P <0.05), 
the data was log-transformed (Y=Log(Y)). The same statistical method was also used to 
compare the concentration of protein carbonyl and MDA between the groups. Correlation 
analyses were first performed in Statistica 13.1 (Dell Inc. Tulsa, OK, USA 2016), but as the 
correlation analyses performed in GraphPad included more data, this was the program used. 
Spearman’s rank correlation analysis was used to look for significant correlations among the 
transcript, content of protein carbonyl, content of MDA, and accumulated teflubenzuron. 
Moreover, CL, total weight, deformities, speckled eyes, black dots and moulting were also 
included in correlation analyses. For the last four parameters, only the x-factor one or zero were 
given. As these are nominal data, Fisher’s exact test was perform at Graphpad’s webpage 













3.2 MORPHOLOGICAL STUDIES 
After 46 days of feeding, the mean CL (mm) was 14.4 ±1.7, 13.4 ±1.8 and 14.1 ±1.9 for control, 
low dose and high dose respectively. The extra control shrimps had an average CL at 16.3 ±1.4.  
The mean body weight (g) was 2.6 ±0.9, 2.2±0.9 and 2.4±0.7 for the control, low dose and high 
dose, and 3.5±1.0 for the extra control shrimps, respectively. A significant difference in CL and 
weight were found between the extra control shrimps and other three treatments, but there was 
no significant difference among the initial controls, low and high dose.  
Moreover, thirteen individuals, four from control and high dose and five from the low dose had 
gone through moulting during the feeding experiment. Deformities like speckled eyes, stiff and 
cracked walking legs were seen on shrimps receiving either low or high dose of teflubenzuron 
(Figure 3.2.1), and five shrimps from the high dose group were found dead. The dead shrimps 
were disintegrated, and could not be examined any further. Moreover, several shrimps, from 
both control, low dose and high dose had black spots on the exoskeleton (Figure 3.2.2). Results 
from Fishers exact test can be found in Table 3.2.3. As can been seen in this table, there were 
significant differences between the control group and the high dose group when comparing 
deformities, black dots and speckled eyes.  Significant differences were also found between the 
control group and the low dose group for the first two parameters. When comparing mortality 
rate between the groups, a significant difference was found between the high dose group and 







Figure 3.2.1: Shrimp from the low dose group                            Figure 3.2.2 shrimp from the low dose group 






Table 3.2.3: Fishers exact test for comparing visible deformities, black dots and speckled eyes among the three 
treatment groups after 46 days of feeding with  either none, a low dose (0.1% of normal fish treatment dose) or a 
high dose (1% of normal fish treatment dose) of teflubenzuron. Control: n=15, low dose: n=17, high dose n=15. 
 
                                                                                                  
3.3 PHARMACOKINETIC ANALYSES/ ACCUMULATION OF TEFLUBENZURON  
The concentration of teflubenzuron (ng/g w.w.) have been summarized in Table 3.3.1. As 
expected, the average concentration of teflubenzuron was higher in the high dose group 
compared to the other treatment groups. However, levels of teflubenzuron higher than LOQ  
were seen in the controls (2.0 ng/g w.w), indicating that the control had been exposed to 
teflubenzuron in some way. To exclude the possibility for error during analysing, same 
procedure was performed with four samples of the initial control shrimps, and ten samples of 
the extra control shrimp from IMR. The mean concentration of teflubenzuron in the extra 
shrimps were lower than the controls, but the concentration of the extra controls were still above 
LOQ (0.7 ng/g w.w). With the lowest concentration at LOQ level, these extra shrimps were 
better suited as controls. However, these additional controls were not included in the feeding 
experiment at Matre Research Station, and this will be discussed later.  
Statistical analyses of accumulated teflubenzuron  during the feeding experiment and the four 
different treatment groups showed a significant difference between high dose treatment and the 
three other treatment groups, extra control (P-value 0.02), control (P-value 0.02) and low dose 
(P-value 0.02) respectively. Moreover, no significant differences were found between 
accumulated teflubenzuron in control and extra control (P-value 0.99).  
Parameters Groups compared P-value Significant 
Deformities Control vs low dose 0.0192   Yes 
 Control vs high dose 0.0020   Yes 
 Low vs high dose 0.4765 No 
Black dots Control vs low dose 0.0029 Yes 
 Control vs high dose 0.0421 Yes 
 Low vs high dose 0.4905 No 
Speckled eyes Control vs low dose 0.2280 No 
 Control vs high dose 0.0063 Yes 
 Low vs high dose 0.1283 No 
Mortality Control vs low dose Not available  
 Control vs high dose 0.0550 No 
 Low vs high dose 0.0498 Yes 
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Table 3.3.1: Concentration of teflubenzuron in pink shrimps, measured at LC-MS/MS after 46 days of feeding 
with either none, a low dose (0.1% of normal fish treatment dose) or a high dose (1% of normal fish treatment 
dose) of teflubenzuron. The extra shrimps were not a part of the feeding experiment. Extra shrimps: n=10 Control: 
n=15, low dose: n=17 , high dose n=15 
 
 
3.4 GENE-EXPRESSION ANALYSES 
To examine oxidation of protein, lipids and DNA (indirectly), genes indicating oxidative stress 
were analyzed at OneStep qPCR and RT-qPCR. For preparation, RNA had to be isolated and 
the quality validated at Bioanalyzer 2100 Expert (Section 2.3.1 and 2.3.2). At first the ratio of 
260/280nm had to be analysed by NanoDrop®, to show if there was any leftover of protein or 
phenol in the samples. For pure RNA a ratio of ~ 2 is often accepted (ThermoScientific, 2010). 
A ratio lower than this indicates contamination. The 260/280 nm ratio was between 2.04-2.21 
for all the samples. For the Bioanalyser 2100 Expert, eight samples were analysed and estimated 
a peak around 42 (Figure 3.4.1). The Bioanalyzer 6000 Nano LabChip Kit is developed for 
mammalian RNA, hence the RNA integrity number (RIN) for crustacean was not available for 
detection. This is because the RIN number give the ratio of the 18S rRNA and the 28S rRNA, 
while in crustaceans the 28S peak is partly or fully missing due to a “gap deletion” or a “hidden 
break” in the 28S rRNA (McCarthy et al., 2015).  During analysing, heat-denaturing forces a 
splicing of the 28S rRNA in crustaceans into two fragments. Due to similar size of the new 
fragments and the 18S rRNA fragment, a single bond with a “degraded” 28S rRNA is formed 
at the 18S position on the electropherogram. With these two peaks at such close positions, no 
ratio between 28S rRNA and 18S position is available for detection, and the RIN number cannot 
be used to validate the integrity of the RNA. Other studies on arthropods have given similar 
explanation to the missing RIN number (McCarthy et al., 2015). 
Group Average 
teflubenzuron 
Min. teflubenzuron Max teflubenzuron 
Control  2.0 ng/g w.w 1.1 ng/g w.w. 2.9 ng/g w.w 
Low dose (B) 6.7 ng/g w.w 1.2 ng/g w.w 24 ng/g w.w 
High dose (A) 70 ng/g w.w 4.7 ng/g w.w 369 ng/g w.w 










Figure 3.4.1: The electropherogram image for the isolated pink shrimp RNA. The two peaks (18S rRNA and 
28rRNA) are too close for a RIN number to be calculated. 
 
3.4.1 GEL-ELECTROPHORESIS 
The RNA synthesized to cDNA though one-step PCR was validated with agarose gel-
electrophorese. Figure 3.4.1.1 shows the gene size determination after separation. The bonds 
are not perfectly clear, but the measured sizes for each gene were easy to detect, and there were 
no double bonds among the genes.  All the genes were between 50-200 bp roughly.   
 









3.4.2 GENE EXPRESSION AND OXIDATIVE STRESS 
After running RT-qPCR, mean normalized expression (MNE) were determined for 12 genes 
respectively. None of the references genes were included as target gene. The efficacy for all 
genes was high (more than 2-fold higher in most cases) and shows the numbers of copied 
fraction of target gene in one PCR cycle. The threshold cycle value (CT), given for each gene, 
tells the measured amount of cycles needed before the fluorescence reaches a specific level for 
detection. The level correlates to the number of nucleic acid present in the samples 
(ThermoFisher, 2016). A mean CT value was calculated for each sample duplicate/triplicate 
and adjusted by the amplification efficiency before using geNorm v3.2 to determine MNE based 
upon actb, rpl13 and uba52 (M-value < 0.8).  
Further statistical analysis was run with GraphPad Prism 7.02. The transcript CuZn-sod was 
excluded from further analysis due to too high PCR efficiency. In GraphPad, the adjusted CT 
sample value for each gene was analysed with ROUT’s test to remove any outliers (GraphPad 
guide, 2017). Comparisons analyses were performed on the three treatment groups, and only 
one significant difference was found (gpx4). The transcript, encoding a protein responsible for 
degradation of hydrogen peroxide in the cells, showed a significant difference between the 
control and the high dose group (P value = 0.0003).  
As for the additional control samples included in this study, seven gene transcripts gave 
statistically significant differences when comparing the means of the three treatment groups 
with the mean of the extra control (Figure 3.4.2.1). Of the seven gene transcripts, four 
transcripts (Mn-sod, gpx4, gclc, gss) were linked to the defence mechanism for oxidative stress, 
two transcripts (cyp3a, gstm3) were linked to detoxification of toxins within the cell, and one 
transcript (ctbs) was linked to the synthesis of chitin.  
Correlation analysis was preform to calculate the association between two variables (correlation 
coefficient) between -1 and +1. The closer the correlation value is towards either -1 or +1, the 
stronger is the relationship between the variables (StatisticsSolutions, 2017). A correlation 
analysis among the transcript, content of protein carbonyl, content of MDA and accumulated 
teflubenzuron, gave a positive correlation  between lipid peroxidation and the oxidative stress 
marker gss (ρ= 0.52) and the marker of chitin-synthesis ctbs (ρ= 0.30). A negative correlation 
was found between the lipid peroxidation and the stress induced protein hsp70 (ρ= -0.35). In 
the protein carbonyl assay, a negative correlation was found with the oxidative stress marker 
cat (ρ= -0, 33) indicating a medium-strong association. 
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Figure 3.4.2.1: Dose-response effects of teflubenzuron exposure in transcripts regulating oxidative stress, 
detoxification and the synthesis of chitin in pink shrimps. (1) gpx1, (2) gpx4, (3) cat, (4) Mn-sod, (5) cyp3a, (6) 
gstm3, (7) gclc, (8) hsp70, (9) bclx, (10) chit1a, (11) gss, (12) ctbs. Control: n=15, low dose: n=17 , high dose 






Both data from the protein carbonyl assay and the lipid peroxidation assay were analysed with 
one-way ANOVA on GraphPad with Holm-Sidak’s post-hoc test (Figure 3.4.2.2). Before 
analysing, outliers were removed with ROUT’s test. A significant difference was found in 
concentration of MDA between the extra control and the three treatment groups from the 
feeding experiment. In the protein carbonyl assay, a significant difference was found between 
the high dose group and the low dose group. Accumulated teflubenzuron gave a significant 
negative correlation with Mn-sod, gpx4, cyp3a, gclc and ctbs, which was medium strong for 
Mn-sod, gpx4,cyp3a and ctbs, and weak for gclc.     
The Spearman correlation analysis was also performed among all parameters; CL, weight, 
deformity, black dots, speckled eyes, moulting, concentration of teflubenzuron, protein 
carbonyl content, MDA content and the transcripts. In this correlation analyse, concentration of 
TFB was positively correlated to speckled eyes and deformity seen after the feeding-
experiment, and negatively correlated to CL and total weight. All correlations mentioned were 
of medium-strong association. Moreover, moulting was negatively correlated to ctbs and 
































































































































* * * * * * * * *
 
Figure 3.4.2.2: Content of protein carbonyl (PC) and lipid peroxidation (LP) in pink shrimp’s tissue exposed to 
teflubenzuron for 46 days at two levels, a low dose (0.1% of normal fish treatment dose) and a high dose (1% of 
normal fish treatment dose). The extra controls were not a part of the feeding experiment. For PC, the significance 
is compared to the high dose group, whereas the significance in LP is compared to the extra controls.   Extra 
shrimps PC: N=9, control PC: N=14, low dose PC : N=15, high dose PC: N=14. Extra shrimps LP: N=9, control 




In the present work, pharmacokinetics and dose-response effects of teflubenzuron were 
examined in pink shrimps after 46 days of feeding with either none, a low dose or a high dose 
of teflubenzuron. Previous studies with teflubenzuron exposed to juvenile lobster showed a 
profound effect on transcriptional changes in gene-expressions connected to detoxification, 
stress and moulting (Olsvik et al., 2015) and toxicological effects like deformities and death 
(Samuelsen et al., 2014). However, pharmacokinetic and the toxicological effects of 
teflubenzuron in pink shrimp had not been investigated earlier. 
 
4.1 THE FEEDING EXPERIMENTS 
In the feeding experiment, the acclimation period was set to 14 days, to minimize the risk of 
mortality from stress when the shrimps were adapted to the new environment. Previous 
unpublished feeding experiments with shrimps, performed by IMR, resulted in high mortality 
among the controls within the first week. In contrast to the previous study, the cages used in 
this experiment were bigger and the acclimation time yielded no mortality among the shrimps. 
However, at the end of the feeding experiment five shrimps were found dead in their cages. 
High doses of teflubenzuron were assumed to be the cause of death, since all the dead shrimps 
were from the high dose group and statistical analyses with Fisher’s exact test  gave a significant 
difference when comparing cumulative mortality between high dose group and low dose group. 
However, when comparing mortality between high dose group and control group, no significant 
difference was recorded. As the numbers (n) of test-species in the groups varied from 15 in the 
control group, to 20 in the high dose groups, n of test-species may have influenced the results.  
The concentrations of teflubenzuron given in this experiment were based on a lethal-dose 
experiment performed by IMR. However, the concentration of teflubenzuron given in the low 
dose (0.01µg/g) was non-lethal to the shrimps in this experiment, and the dose was probably 
too low for the shrimps to respond strongly. Moreover, the medical pellets were only given two 
days a week for 46 days, in contrast to a 7-day medication period given to salmonids, where is 
reasonable to think that aquatic animals can be exposed daily during medication.  When 
comparing with a study on mortality and deformities in European lobster juveniles exposed to 
teflubenzuron, doses of 20 mg/kg and 10 mg/kg (same as the daily dose given in marine 
salmonid farms) were given for 4 or 7 days depending on weight. After 3 months of monitoring, 
38% (n=42) of the lobster died in the high dose group, and  41% (n =46) died in the low dose 
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group (Samuelsen et al., 2014).  The high dose (20 mg/ kg) in the study by Samuelsen et al. 
(2014) was chosen from concentrations found in faecal material from medicated salmons. With 
the finding of such high concentrations in salmon faeces during medication, both doses of 
teflubenzuron given in this experiment were low in comparison, indicating that shrimps can be 
exposed to higher concentrations in nature. However, the accumulated levels of teflubenzuron 
varied greatly within the surviving shrimps from the high dose groups (4.7 ng/g w.w to 369 
ng/g w.w). Uneaten pellets could explain some variation, as pellets might be lost from the cage 
during the feeding trial, or there might be a difference in appetites/ behaviour among the 
shrimps. A difference in behaviour could be due to sex or moulting status. As shrimps are 
usually protandric (change sex from male to female during their life cycle)(Wieland, 2004; 
Bauer, 2007), sex also might have an impact on size and age. The correlation analysis showed 
a negative significant association between concentration of teflubenzuron and weight, which 
might indicate that accumulated concentrations of teflubenzuron had a direct effect on growth 
by impacting moulting frequency or by redirecting energy from growth towards detoxification. 
There have been several toxicological studies on the effect of diflubenzuron in crustacean, 
where the drug has caused retardation of regeneration (Weis et al., 1992) and has had an effect 
on behaviour (Savitz et al., 1994).  According to Weis et al. (1992) regeneration and moulting 
in crustaceans are often linked together and controlled by the neuroendocrine system, and that 
most studies reports an effect on both regeneration and moulting when studying the response to 
pollutants in crustacean (Weis et al., 1992). Moreover, the deep-water shrimp (Pandalus 
borealis) change sex in spring or in  summer (Bauer, 2007), and as the feeding trial took place 
in the spring, the drug may have had an effect on the sex change from male to female. 
Differences in body fat content can also explain some variations, as the drug is highly lipophilic. 
Moreover, moulting can also lead to the elimination of some of the chemical when the old 
exoskeleton is shed. At the end of the feeding experiment pieces of the old exoskeleton was 
remained in some cages, and the old exoskeleton could have contained some teflubenzuron. 
Overall, it seems like there might be an individual difference in uptake and accumulation of 
teflubenzuron among the shrimps, and that the drug negatively affects the regeneration in 
shrimps. A difference in accumulated levels of teflubenzuron among individuals was also seen 
in the study of juvenile European lobster one day after the 7-days medication period ended 




Furthermore, this experiment had some limitation, as age and exact time of moulting for each 
shrimp were unknown. In an extended experiment with larger n, variable age would have had 
less impact on the studied parameters. In this case, one cannot exclude natural reasons as a 
cause of death. Previous studies have indicated that adult crustaceans are more tolerant to 
toxicant than larval form (Roth et al., 1993), but with mature shrimps as test-species, size-
dependent effects on tolerance were probably negligible. 
At the end of the feeding experiment, four shrimps from the control group and the high dose 
group and five shrimps from the low dose group had gone through ecdysis (moulting). Pieces 
of the old exoskeleton were found in the cages, and for some, the newly developed exoskeleton 
were still soft. As shrimps often feed off their old skeleton, leftover of exoskeleton may indicate 
that the shrimps had newly been through moulting, especially in individuals with soft 
exoskeleton. Moreover, it is known from the literature that exposure of teflubenzuron prior to 
moulting negatively affects formation of a new exoskeleton, by inhibiting the synthesis of 
chitin. If the shrimps were recently past moulting, it is reasonable to think that shrimps from 
the high dose group would not be alive if the feeding experiment had continued for some more 
weeks. In addition, deformities were seen in all shrimps that had gone through moulting in the 
high dose group, confirming the toxicological effects of teflubenzuron in the moulting stage.  
In the literature, deformities have been mentioned as an outcome of teflubenzuron exposure, 
and abnormal swimming have been reported from studies of crustacean exposed to 
diflubenzuron (Roth et al., 1993). As teflubenzuron in considered more potent than 
diflubenzuron, lower concentration of the chemical should in theory yield similar deformities. 
In this work, deformities like stiff and crocked legs were seen in individuals from both treatment 
groups. Walking leg and claw deformities have previously been reported in juveniles European 
lobster exposed to teflubenzuron in doses of 5% and 20% of the daily dose given to salmons 
(10 mg/kg) for 114 days (Olsvik et al., 2015), suggesting that teflubenzuron can cause 
deformities in crustaceans even when small doses of the chemical are given.  
The black spots, seen in many individuals across the groups, seems to have derived from 
another source than teflubenzuron. The most reasonable explanation has been proposed in an 
article on black spotted shrimps, that claimed oxygen to be the cause of black spots (melanins), 




4.2 PHARMACOKINETIC ANALYSES/ ACCUMULATION OF TEFLUBENZURON 
In the pharmacokinetics studies, concentrations above LOQ were found among the initial 
control shrimps (Figure 4.2.1). Therefore, these controls were reanalysed with the extra control, 
concentrations above LOQ were found in both groups, the controls and in the additional 
controls. Although the concentrations were 2.7-fold lower in the extra controls. As the 
analytical method is developed by NIFES and was performed with an analyst well known with 
the method, errors during sample preparation and extraction are unlikely. In addition, tissue 
from shrimps bought at Bryggen, in Bergen, was used as blank and they did not contain residues 
of teflubenzuron above LOQ.  This indicated that the controls and the extra controls had been 
exposed to teflubenzuron.  However, a possible explanation for exposure of teflubenzuron could 
be contamination during feeding at Matre Research Station. The pellets given to the shrimps 
were coated with a mixture of glucose, teflubenzuron and cod-liver oil, and by accident the 
same tweezer were used to feed all shrimps groups. If the shrimps were fed in correct order: 
controls, low dose and high dose, and the tweezer was properly cleaned in between, the risk of 
contamination should have been minimal. In this case, many people were involved in the 
feeding process, and therefore the possibility of incorrect feeding order or improperly cleaning 
of tools or hands during feeding should be considered. The tanks holding the extra controls had 
also previously been used for other feeding experiments with teflubenzuron, and due to high 
lipophility, leftovers of teflubenzuron could have been present in the walls of the tanks. This 
possibility is considered less likely, as the tanks had been properly cleaned between each 
feeding experiment. Moreover, as the chemical is in use as a treatment against salmon lice in 




Figure 4.2.1: Concentration of teflubenzuron found in the shrimps from Matre Research Station and the extra 
control given from IMR. The picture below (2) is an enlarged section of the picture above (1), and the section is 





4.3 TRANSCRIPTIONAL STUDIES OF TEFLUBENZURON IN SHRIMPS 
Detection of teflubenzuron in the initial controls had no implications on pharmacokinetic 
analyses. For the molecular and biochemical studies on the other hand, it might have made a 
difference, and the extra shrimps were included in the statistical analyses, even though they 
contained teflubenzuron as well. However, there were some challenges to consider if the extra 
shrimps should be involved in these analyses. Due to fact that these shrimps were obtained from 
IMR months later and had been  kept and fed in the lab for a longer period of time, they did not 
meet the criteria as proper controls for the 46-days feeding experiment. There was also a 
statistical difference in weight and CL between the extra control and the other groups, which 
can affect metabolic analyses. On the other hand, the extra shrimps were from the same catch, 
had been fed with the same feed pellets as the controls, and had lived in tanks with similar water 
temperature as the initial shrimps. With no ideal control group in this experiment, the extra 
shrimps were included in all sample analyses as they contained considerable less teflubenzuron 
that the original controls. 
 
4.3.1 GENE-EXPRESSION ANALYSIS 
For the gene-expression analysis, the integrity of potential PCR primers were tested with gel-
electrophorese before running RT-qPCR. In addition to the twelve genes analyzed in this 
current work, gel-electrophorese indicated that the transcript CuZn-sod was usable for RT-
qPCR. However, as Figure 3.3.5.1 shows, the PCR efficiency for CuZn-sod was far above upper 
acceptable limit (3.687, should be between 1.80-2.10). A high PCR efficiency for CuZn-sod 
could be explained by coamplication of nonspecific products like primer dimer during RT-
qPCR, or by high levels of inhibitors in sample. Pipetting error when making the standard curve, 
could also lead to an increased PCR efficiency, but as the same standard curve was used for all 
the primers, this cannot explain the high efficiency alone (BioRad, 2006). However, pipetting 
error could been an explanation to why all the PCR-efficiencies were slightly higher than the 
desirable efficiency value. In addition, the RT-qPCR machine was newly approached by 
NIFES, and the calculated PCR efficacy in the new machine was higher compared to the old 
machine. This suggest that type of qPCR machine has an impact on estimated efficiency. Svec 
et al. (2015) also saw a significant difference in estimated efficacy between several q-PCR 
machines in their study, probably due instrument and software settings, and differences in 
algorithm used to detect CT-value.  
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4.3.2 RESULTS FROM STATISTICAL ANALYZES 
Only one out of twelve genes responded significantly to exposure of teflubenzuron when 
comparing gene-expressions with the initial groups from the feeding experiment. The transcript 
(gpx4) was significantly lower expressed in the high exposure group compared to the control 
group. Although Figure 4.3.2.1 shows a decreased expression from the control group towards 
the high dose group, no significant differences were found between the low dose group and the 
controls. A decrease in expression of genes encoding GPX4, may suggest that teflubenzuron 
can cause a disruption of the antioxidative defence. However, with an unbalance in pro-
oxidants/antioxidants one should expect a significant difference in expression of other ROS 
regulators like the SOD enzymes, seen in a study with pacific white shrimps exposed to 
ammonia (Liang et al., 2016), or CAT,  suggested to play an important part of the antioxidative 
defence in invertebrates (Livingstone, 2001). In contrast to GPX, CAT showed a similar or a 
higher activity in invertebrates compared to vertebrates in the study (Livingstone et al., 1992). 
However, a difference in the antioxidative defence mechanism between aquatic species have 
been seen (Livingstone, 2001), and there is limited information about the antioxidative defence 
mechanism in shrimps. Moreover, levels of mRNA do not necessary reflects the activity of the 
protein, and a study by Liu et al. (2007) showed an increase activity of GPX 12 hours after 
injecting shrimps with the bacteria V. alginolyticus (Liu et al., 2007).  A significant decrease in 
the high dose group for genes encode GPX-4, and non-significant expressions of genes 
encoding other ROS regulators (mnsod, cat ,gclc, gss), will only suggest a weak association 




































Nevertheless, when comparing the MNE of the extra controls with the other groups, the results 
suggest that detectable concentrations of teflubenzuron in the control group could be a reason 
why no-significant differences in expressions were measured. When comparing the mean of the 
extra control with the other treatment groups, a difference in transcripts involved in mechanisms 
connected to oxidative stress (Mn-sod, gpx4,gclc, gss), detoxification (cyp3a,gstm3) and chitin 
synthesis (ctbs) were found. For all transcripts, a significantly decrease in MNE was seen 
between the extra controls and the high dose group. This reduced level of expressions in the 
exposed groups were significant for most genes, with one exception (gss), which showed 
difference only between the extra controls and the initial controls. With a significant decreased 
expression in genes encoding CYP3A, GSTM3 and CTBS, the comparison with the extra 
controls, indicates that teflubenzuron might deactivate detoxification mechanism in cells, and 
that the drug affects the post-moulting phase by inactivation of CTBS. Previous studies have 
suggested that the cytochrome P450 enzymes (family 2 and 3 more specifically) are important 
regulators of detoxification processes in shrimps (James and Boyle, 1998), and a decrease in 
transcripts encoding CYP3A can be explained by a toxic effect of tefubenzuron impacting the 
cytochrome P450 system. Regulation of CTBS on the other hand, is influenced by stage of 
moulting, and results from a study by Zou and Fingerman (1999) showed a significant increase 
in CTBS activity in crabs prior to moulting (Zou and Fingerman, 1999). Several of the initial 
shrimps had gone through moulting at the end of the feeding experiment, which can explain a 
decreased activity of the CTBS enzymes for these three groups. Unfortunately, no data were 
available for moulting status in the extra shrimp group. An increase of CTBS activity in the 
extra controls may suggest that several of the extra shrimps were in a pre-moulting phase. In 
addition, the Spearman’s rank correlation analysis also indicated a negatively correlation with 
ctbs and moulting, which suggest the expression of genes encoding CTBS increases when the 
shrimps are not moulting. This can further support the results from the study by Zou and 
Fingerman (1999), which indicated that CTBS activity increased at the pre moulting stage, and 
decreased at the post-moulting stage. Moreover, correlation analysis with accumulated 
teflubenzuron levels gave a significant relation with the transcripts linked to oxidative stress 
(Mn-sod,gpx4 gclc), detoxification (cyp3a) and chitin synthesis (ctbs), which all responded 
significantly different by including the extra controls. The correlation coefficients were 




When using whole animal tissue it is difficult to measure tissue-specific effects of 
teflubenzuron, as there may be known or unknown substances within the organism that interacts 
with the drug tested (Murphy, 1991). As the extra controls had been fed for a longer time, the 
content of minerals and fat in their diet can explain some differences in transcriptional levels 
between the groups. Moreover, in the The European Agency for the Evaluation of Medicinal 
products (EMEA) studies of salmon exposed to teflubenzuron, the highest concentrations of the 
drug were found in liver, gut and kidney (EMEA, 1999). When including all organs of the 
shrimp, expressions from many different types of cells are measured in one analyse. As the 
gene-expression varies between organs and tissue (Robalino et al., 2007), responses from 
sensitive cells may be obscured by stronger responses from less active and more abundant  cell 
types, like muscle cells. It is known that the hepatopancreas plays a major role in detoxification 
of substances in shrimps, hence the amount of genes linked to detoxification might be greater 
in tissue from the hepatopancreas (Sreeram and Menon, 2005). Furthermore, studies in juvenile 
European lobster exposed to teflubenzuron showed an effect on transcription of genes linked to 
detoxification in claw tissue (Olsvik et al., 2015), while in an unpublished study, isolation of 
high quality RNA from leg-tissue in shrimps failed. Even though studies with teflubenzuron 
exposure to insect  have shown an impact on a numerous tissues and cells, (Merzendorfer, 
2013), it seems like the use of specific tissue cells, from organs like the hepatopancreas might 
be preferable in toxicological studies in shrimps. Furthermore, antioxidative activity is shown 
to vary with age, season and moulting (Livingstone, 2001). With a small n, lack of data on age 
and moulting can affect the results from the transcriptional studies and the colorimetric analyses 
of MDA levels and protein carbonyl concentration indicating oxidative stress. The two latter 
will be discussed next.  
Oxidative stress can be induced by contaminates, and provoke DNA oxidation, lipid oxidation 
and protein oxidation. In this study, kit to measure content of protein carbonyl and content of 
MDA was used in addition to gene expression analysis, to look for signs of oxidative stress in 
the shrimps.  Protein oxidation can lead to the formation of protein carbonyl, and the content of 
protein carbonyl were measured with the protein carbonyl colorimetric assay.  The results gave 
a significant difference in content between high dose group and low dose group. Figure 3.3.2 
shows a small, but non-significant increase in content of protein carbonyl from the controls to 
the low dose group, and a large significant decrease from the low dose group to the high dose 
group. As the content of protein carbonyl indicates oxidative stress, a higher content of protein 
carbonyl should be expected in the high dose group. However, it seems like the content of 
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protein carbonyl increases before it reaches a threshold and then decreases. This pattern could 
either be explained by a stronger activation of defence mechanism when the threshold limit is 
reached, or due to the breakdown of proteins. Correlation analysis gave a significant negative 
correlation between protein carbonyl and the oxidative stress regulator cat, which plays a part 
in catabolizing hydrogen peroxide into oxidized glutathione and water. Catabolizing hydrogen 
peroxide prevent the specie from attacking lipids or proteins, and a positive correlation between 
cat and content of protein carbonyl should be expected as one would think that higher content 
of protein carbonyl would induced an increased activation of CAT-enzymes.  
Free oxygen radicals attacking polyunsaturated fatty acid generate the main product of lipid 
peroxidation, MDA. Concentration of MDA could therefore be an indication for oxidative 
stress, and were measured with the lipid peroxidation assay in this study. The measured MDA 
content showed a significant difference between the extra controls and the three treatment 
groups, but no significant difference was found between the initial controls and the treated 
groups. The mean MDA content between the initial treatment groups were similar, indicating 
that exposure of teflubenzuron did not affect lipid peroxidation in the shrimps. However, the 
higher levels of MDA in the extra controls was unexpected. One would assume that this level 
would be even lower than with the initial groups, as the additional controls contained 
considerable less teflubenzuron. This could be explained by the duration of feeding and likely 
reflect changed fatty acid composition of the animals kept longer in the lab. Correlation analysis 
on MDA content gave a significant connection with gene involved in stress regulation (hsp70), 
chitin synthesis (ctbs) and regulation of oxidative stress (gss). A correlation between expression 
of genes involved in the oxidative defence mechanism and lipid peroxidation justifies 
application of the colorimetric method of measuring MDA content in this work.  
Correlation analyses with accumulated teflubenzuron did not show any association between the 
content of protein carbonyl and content of MDA. This may suggest that the applied doses of 
teflubenzuron did not induce detectable oxidative stress in the exposed shrimps. However, as 
the transcripts linked to oxidative stress (Mn-sod, gpx-4, gclc) were negatively correlated to 
accumulated teflubenzuron, and there was a significant difference in content of protein carbonyl 
between high dose groups and low dose group, the current study indicates that teflubenzuron 






8. CONCLUSION  
This study shows that pink shrimps can accumulate quit high levels of teflubenzuron after 46 
days of exposure. The accumulated levels of teflubenzuron in shrimps from the two exposed 
groups suggest that there are individual differences in uptake and accumulation of 
teflubenzuron, and that the drug has an impact on growth.  This could possibly be linked to feed 
intake and moulting stage of shrimps at sampling. The findings from the morphological studies 
indicate that even small doses of teflubenzuron can cause deformities in shrimps, and that the 
highest dose of teflubenzuron (0.1µg/g) can lead to death.  
For the molecular and biochemical part of the experiment, high doses of teflubenzuron seem to 
induce weak oxidative stress, even though correlation analyses with accumulated teflubenzuron 
did not give any significant association between content of MDA and content of protein 
carbonyl. Surprisingly, the control shrimps contained teflubenzuron above LOQ, rendering 
















7. FURTHER STUDIES 
In the current work, detectable levels of teflubenzuron were found in the controls. This might 
have rendered the controls sub-optimal for the molecular and biochemical parameters measured 
in the shrimps. With available time, the experiment should be repeated ensuring the controls 
contain no teflubenzuron. Future studies should also focus on tissue-specific responses to 
teflubenzuron exposure, especially on the hepatopancreas as the main detoxifying organ in 
crustaceans. Moreover, there is still a need for more information about the impact on 
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FEEDING RECORD AT MATRE RESEARCH STATION 
Weights: 
Mean-weight shrimps: 4.36 ±1.17g   
Mean-weight pellets: 0.12g 
Doses: 
1% of 10 mg/kg daily fish therapy dose.  
10 mg/kg = 10 µg/g 
1% of 10 µg/g = 0.1 µg/g, which gives a dose of 0.44 µg per pellet given to a shrimp of 4.4 g. 
0.1% of 10 µg/g = 0.01 µg/g, which gives a dose of 0.044 µg per pellet given to a shrimp of 4.4 
g. 
1200 pellets have a weight of approximately 144 g 
Dose 1 %. (Dose A) 
0.44 µg per pellet x 1200 pellets= 528 µg teflubenzuron coated on 144 g pellets.  
Preparations: 
10 mg of teflubenzuron  was mixed with  10 g glucose, which gave a concentration of 1 mg/g 
(1000 mg/g). Then 528 mg of  the 1 mg/g-mix, was mixed with 2.5 g glucose and coated on 
144 g pellets. 
Dose 0.1% (Dose B) 
0.044 µg per pellet x 1200 pellets= 52,8 µg teflubenzuron coated on 144 g pellets. 
Preparations:  
1 g from the 1mg/g-mix was mixed with 9 g glucose to a concentration of 100 µg/g. Then 528 





TABLE 2A. SETUP FOR THE STANDARD CURVE IN THE PHARMACOKINETIC ANALYSIS 
 Added 50 ng/mL 
(5 µg/mL*)   
standard  
(µL) 
Concentration in the 
samples (ng/g) 
Added IS 




BUM   200  
BMM   200  
N1 20 1 200 K1 
N2 80 4 200  
N3 200 10 200 K2 M1 M2 M3 
N4 400 20 200  
N5 600 40 200  
N6 800 50 200  
N7 10* 50 200  
N8 20* 100 200 K3 
N9 30* 150 200  
 






































































Teflubenzuron 379.0 -> 339.0
Teflubenzuron 379.0 -> 195.9
Diflubenzuron-d4 313.0 -> 293.1
 
 











(ng/g w.w) Notice 
1 16.4 4.15 0.57 1.4 control 
2 13.3 2.32 0.56 1.1 control 
3 15.8 3.20 0.59 1.9 control 
4 14.1 2.00 0.53 2.9 control 
5 14.1 1.74 0.52 2.6 control 
6 13.6 2.12 0.52 2.8 control 
7 15.1 2.86 0.62 1.6 control 
8 10.8 1.14 0.46 2.7 control 
9 11.8 1.57 0.51 1.5 control 
10 13.3 1.86 0.50 2.0 control 
11 15.5 2.85 0.54 2.7 control 
12 15.9 3.20 0.54 1.4 control 
13 14.9 2.97 0.50 1.2 control 
14 17.1 4.11 0.57 1.8 control 
15 14.2 2.37 0.54 1.6 control 
16 12.9 1.91 0.53 2.2 Low dose 
17 14.6 2.65 0.53 24 Low dose 
18 13.4 2.22 0.51 8.1 Low dose 
19 15.7 3.48 0.68 5.8 Low dose 
20 15.3 3.49 0.65 1.8 Low dose 
21 11.5 1.42 0.52 1.6 Low dose 
22 16.8 4.02 0.65 1.2 Low dose 
23 10.0 1.10 0.40 9.4 Low dose 
24 13.0 1.88 0.51 3.7 Low dose 
25 16.2 3.22 0.61 3.8 Low dose 
26 14.4 2.79 0.51 3.3 Low dose 
27 13.4 2.01 0.53 5.1 Low dose 
28 11.8 1.68 0.51 13 Low dose 
29 12.6 1.52 0.52 10 Low dose 
30 12.8 1.67 0.53 11 Low dose 
31 12.2 1.52 0.50 2.5 Low dose 
32 11.6 0.97 0.43 6.9 Low dose 
33 13.4 2.26 0.52 23 High dose 
35 13.0 1.94 0.52 7.6 High dose 
37 10.8 1.15 0.49 8.2 High dose 
38 13.8 2.20 0.52 25 High dose 
39 15.1 2.47 0.50 14 High dose 
40 14.8 2.79 0.53 17 High dose 
41 15.5 3.16 0.53 23 High dose 
































43 14.8 2.86 0.5 93 High dose 
45 15.3 3.05 0.52 7.6 High dose 
46 16.8 3.43 0.60 4.7 High dose 
47 16.3 3.24 0.51 149 High dose 
48 12.9 1.86 0.54 11 High dose 
50 14.4 2.29 0.51 4.9 High dose 
51 15.1 2.78 0.56 369 High dose 
1 18.3 5.0 0.49 0.51 Extra control 
2 16.6 4.0 0.51 0.80 Extra control 
3 14.1 5.0 0.49 0.84 Extra control 
4 18.2 3.0 0.47 0.88 Extra control 
5 16.5 3.0 0.48 0.87 Extra control 
6 16.4 3.0 0.59 0.85 Extra control 
7 14.6 3.0 0.48 0.20 Extra control 
8 15 3.0 0.51 0.26 Extra control 
9 16.1 3.0 0.48 1.1 Extra control 




TABLE 3A. REVERSE TRANSCRIPTASE MIX  
 
 Reagens 50 µL µL added RT mix 
plate 1 (x 102) 
µL added RT mix 




ddH2O 8.9 907.8 801 
 10X TaqMan RT 
buffer 
5.0 510 450 
 25mM magnesium 
chloride 
11.0 1122 990 
 10mM deoxyNTPs 
mixture (2.5mm of 
each dNTP) 
10.0 1020 900 
 *50µM oligo d(T)16 2.5 255 225 
Enzymes  RNase inhibitor 
(20U/µL) 





1.67 170.34 150.3 
 
TABLE 3B. REVERSE TRANSCRIPTASE REACTIONS TERMS 
 
Steps Incubation RT Reverse transcriptase 
inactivation 
End 
HOLD HOLD HOLD HOLD 
Temperature 
(°C)  
25 48 95 4 
Time (min) 10 60 5 ∞ 
Volume (µL)  50   
 
TABLE 3C. SYBR GREEN MASTER MIX 
 
Reagents Volum each sample 
(µL) 
µL added mix plate 1 µL added mix plate 2 
SYBR GREEN 
Master mix 
5 575 505 
ddH2O 2.8 322 283 
Primer fw (50µM) 0.1 11.5 10.1 





































TABLE 3E. QIAGEN ONESTEP RT-PCR 
 
Components 25µL rxn* µL added  Final concentration 
5 x QIAGEN OneStep 
RT-PVR buffer 
5 µL 40 1x 
Q solution 5 µL 40 5x 
dNTP mix (10mmM 
of each dNTP) 
1 µL 8 400 µM of each dNTP 
Primer forward 0.3 µL  0.6 µM 
Primer revers 0.3 µL  0.6 µM 
RNase inhibitor 0.25 µL 2  
QIAGEN OneStep 
RT-PCR enzyme-mix 
1 µL   
ddH2O 11.35 µL 90.8 Up to 25 µl incl. 
template RNA 
Template RNA 0.8 µL 6.4 Ca 0.5-1 µg RNA 
 
Step Time Temperature Comment 
Reverse transcriptase 30 min 50°C Can increase to 60°C 












45 sec (30-60) 
 



















Ca. 5°C under 
primers Tm 
Increase with 30-60 














CALCULATION OF THE CONCENTRATION OF CARBONYL IN THE SAMPLES FROM THE 
ABSORBANCE VALUE 
 
CA = Average absorbance samples – average absorbance controls  
Protein Carbonyl (nmol/ml) = [(CA)/(*0.011 µM-1)](500 µl/ 200µl) 
 














1 24.2 Control 33 45.3 High dose 
2 44.0 Control 35 20.9 High dose 
3 40.1 Control 37 16.5 High dose 
4 39.3 Control 38 37.4 High dose 
5 88.9 Control 39 31.8 High dose 
6 71.5 Control 40 21.6 High dose 
7 44.4 Control 41 22.2 High dose 
9 49.3 Control 43 20.5 High dose 
10 52.2 Control 45 24.7 High dose 
11 58.5 Control 46 29.0 High dose 
12 31.7 Control 47 29.1 High dose 
13 34.1 Control 48 -28.2 High dose 
14 42.5 Control 50 29.2 High dose 
15 23.3 Control 51 -80.4 High dose 
16 27.9 Low dose 1 5.60 Extra control 
17 27.1 Low dose 2 69.7 Extra control 
18 23.1 Low dose 3 55.9 Extra control 
19 30.8 Low dose 4 75.8 Extra control 
20 37.6 Low dose 5 66.4 Extra control 
21 99.6 Low dose 6 59.9 Extra control 
22 135 Low dose 7 1.45 Extra control 
24 103 Low dose 8 23.5 Extra control 
25 -115 Low dose 9 27.5 Extra control 
26 71.5 Low dose 10 61.7 Extra control 
27 47.2 Low dose    
28 48.9 Low dose    
29 49.2 Low dose    
30 70.2 Low dose    
31 56.5 Low dose    
 
 
CALCULATION OF THE CONCENTRATION OF CARBONYL IN THE SAMPLES FROM THE 
ABSORBANCE VALUE 
 
Background = the blank MDA standard 
Absorbance for each samples and standards = Measured aborbance – background 
(Sa –Sv) x D = concentration of MDA (nmole/µL) 
Sa = Amount of MDA in the unknown sample 
Sv = sample volume added to wells (µL) 













FIGURE 4B. STANDARD CURVE 1, 2 AND 3 
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(nM/µL) Notice Shrimp no. 
MDA 
(nM/µL) Notice 
1 0.75 Control 33 0.86 High dose 
2 0.80 Control 35 1.6 High dose 
3 0.81 Control 37 0.95 High dose 
4 0.77 Control 38 0.85 High dose 
5 1.2 Control 39 0.90 High dose 
6 1.4 Control 40 0.97 High dose 
7 1.3 Control 41 1.1 High dose 
8 1.4 Control 42 1.1 High dose 
9 0.71 Control 43 0.47 High dose 
10 1.0 Control 45 1.0 High dose 
11 1.0 Control 46 0.42 High dose 
12 0.83 Control 47 0.98 High dose 
13 0.75 Control 48 0.65 High dose 
14 0.68 Control 50 0.55 High dose 
15 0.32 Control 51 0.83 High dose 
16 0.58 Low dose 1 1.7 Extra control 
17 0.99 Low dose 2 0.71 Extra control 
18 0.90 Low dose 3 1.2 Extra control 
19 0.73 Low dose 4 1.3 Extra control 
20 0.90 Low dose 5 1.7 Extra control 
21 1.3 Low dose 6 1.5 Extra control 
22 0.87 Low dose 7 0.94 Extra control 
23 0.86 Low dose 8 1.3 Extra control 
24 0.80 Low dose 9 1.5 Extra control 
25 0.75 Low dose    
26 1.3 Low dose    
27 0.78 Low dose    
28 1.1 Low dose    
29 0.82 Low dose    
30 1.2 Low dose    










TABLE 5A. CORRELATION ANALYSES. GREEN MARKS SIGNIFICANT CORRELATIONS.  
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